Study of Anti-cysticercal Antibodies to Taenia Solium in the

Serum of Epileptic Patients in Tertiary Care Hospital. by Arthi, E

	
		

	

 
	

				

	



	
		


	

	


	



 




	
 






























 	
	   	
	
		



	
	
APRIL 2013 

 


This is to certify that this dissertation entitled “STUDY OF ANTI-
CYSTICERCAL ANTIBODIES TO TAENIA SOLIUM IN THE 
SERUM OF EPILEPTIC PATIENTS IN TERTIARY CARE 
HOSPITAL” is the bonafide original work done by Dr.ARTHI E, Post 
graduate in Microbiology, under my overall supervision and guidance in 
the department of Microbiology, Stanley Medical College, Chennai, in 
partial fulfillment of the regulations of The Tamil Nadu Dr. M.G.R. 
Medical University for the award of M.D Degree in Microbiology 
(Branch IV).
 
 
 
 
Dr. S. Geethalakshmi, M.D.,     Dr. R.SELVI, M.D., 
Dean    Prof. & H.O.D. 
Stanley Medical College       Department of Microbiology 
Chennai-600 001       Stanley Medical College 
  Chennai-600 001. 


 

 
	


I solemnly declare that this dissertation “STUDY OF ANTI-
CYSTICERCAL ANTIBODIES TO TAENIA SOLIUM IN THE 
SERUM OF EPILEPTIC PATIENTS IN TERTIARY CARE 
HOSPITAL”is the bonafide work done by me at the Department of  
Microbiology, Government Stanley Medical College Hospital, Chennai, 
under the guidance and supervision of  Prof. Dr.R.SELVI, M.D., 
Professor and head of department of Microbiology, Government Stanley 
Medical College, Chennai-600 001. 
This dissertation is submitted to The Tamil Nadu Dr. M.G.R. 
Medical University, Chennai in partial fulfillment of the University 
regulations for the award of degree of M.D. Branch IV Microbiology 
examinations to be held in April 2013. 
 
 
 
Place: Chennai. 
 
Date :        
 
 
 
 
 
                                                                                    Dr. ARTHI E 
 
 
             

                                  ACKNOWLEDGEMENT 
 
I thank the ALMIGHTY for blessing and giving me the health and 
ability for carrying out this work successfully. 
  I sincerely acknowledge and wish to express my thanks to 
Professor Dr.S.Geethalakshmi M.D, Dean, Stanley Medical College and 
Hospital, Chennai, for granting  permission to utilize the facilities of this 
Institution for the study. 
I express my warmest respects and profound  gratitude to Dr. 
R.SELVI, M.D., The Professor and Head of The Department, 
Department of Microbiology, Govt. Stanley Medical College, Chennai, 
for her able guidance, constant encouragement and support during the 
course of the study.  
The author is extremely thankful to DR.SC PARIJA M.D.,PhD , 
Head of the department of Microbiology, JIPMER , Puducherrry for his 
guidance and technical support during this study to do Enzyme Immuno 
Transfer Blot (EITB) at his institution. 
Im extremely thankful to  Dr.Gopinathan   M.D.DM, Professor 
and Head of the , Department of Neurology,  for granting permission to 
collect blood samples from patients and for his constant guidance 
The author expresses her sincere gratitude to 
Dr.A.VASUMATHI,M.D,    DR.EUNICE SWARNA JACOB M.D., 
DR PRABAKARAVARTHANAN M.D.,  .,DR.SHANTHI,M.D., 
DR.HEMA M.D., Assistant Professors for their guidance and 
encouragement.  

The author owes special thanks to Dr. DAVID AGATHA M.D., 
DR.USHA KRISHNAN M.D., our former Assisstant Professors of 
Microbiology for their valuable guidance and support. 
The author expresses her special thanks to her colleagues for their 
immense help, constant encouragement and unconditional support 
throughout the study. 
The author gratefully acknowledges the help rendered by Mr. 
Albert, Statistician, during the statistical analysis of the study. 
The author is indebted to the patients and the persons from whom 
blood samples were collected for conducting the study. 
Finally, the author expresses her special thanks to her family 
members for the moral support and encouragement extended by them


 
 
 
 
 
 
 
 

 
                                                 CONTENTS 
 
SL.NO.                    TITLE           PAGE NO.   
1. 	 1 
2. AIM OF THE STUDY 5 
3. REVIEW OF LITERATURE 6 
4. MATERIALS AND METHODS 31 
5. OBSERVATIONS &RESULTS 54 
6. DISCUSSION 73 
       7. SUMMARY 87 
8. CONCLUSION 90 
 ANNEXURES 
  I ) APPENDIX          
 
   II) BIBLIOGRAPHY  
 III) MASTER CHART   
 IV) PROFORMA  

 

INTRODUCTION  
 
         Cysticercosis is a parasitic infection of the larval form of the 
zoonotic  cestode , Taenia solium.  When humans are infected with the 
adult worm or the larval stage it causes Taenisis and Cysticercosis 
respectively. Infection of the central nervous system with the larval form 
is called Neurocysticercosis (NCC).  It is the most common parasitic 
infection of the central nervous system[27,28]. It is also the leading cause of 
epilepsy in the developing world [3,29,60] .Neurocysticercosis is a disease 
associated  with poverty and poor hygienic practices . It is the disease of 
major public health importance in the developing countries especially 
Latin America, India, Africa and China [64].  Recently, there has been 
rising trends of the disease in the developed countries due to ease of 
international travel and increasing immigrants from the endemic areas [60].  
About 2.5 million people  worldwide are tapeworm carriers and  nearly 
20 million people are infected with cysticerci [38] . Cysticercosis / 
Taeniasis is emerging as a serious public health and agricultural problem 
in many developing areas of the world. 
 
          Neurocysticercosis presents with varied clinical manifestation. 
Epileptic seizure is the most common presentation seen in 70-90% of the 

cases [76, 16]. NCC is the most common cause of late onset epilepsy in 
areas of endemicity[41] . Epilepsy due to NCC is a major problem in 
tropical developing countries. A recent meta-analysis of published studies 
has estimated that about 29.6% (95%CI: 23.5%-36.1%) of epilepsy cases 
in the NCC endemic countries are associated with NCC lesions in brain 
identified by neuroimaging [13]. NCC may also act as a risk factor for 
stroke [14] and migraine-type headaches.  
       There is an immense burden of epilepsy in the developing countries 
like India, than developed countries like the West.  Three quarters of the 
estimated 50 million people with epilepsy live in the poor countries of the 
world and 94% of them remain untreated [6, 69].  But little is known about 
the causes of epilepsy in developing countries. According to many studies 
from Latin America, infestation of brain with the larval stage of the 
parasite, T.solium is found to be the important cause of epilepsy in 
developing countries [65, 62.]. Data regarding the prevalence of epilepsy due 
to NCC is unavailable in India though in some areas it is reported more 
frequently [37].  
        Neurocysticercosis is of great economic relevance, resulting from 
the cost of medical treatment, lost working days, and losses due to 
livestock condemnation [11]. It a disease of great economic loss especially 

in pig farming communities. The pig production is markedly affected due 
to cysticercosis , resulting in condemnation of live pigs or carcasses at 
meat inspection and reduction in their commercial value[60]. 
             Diagnosis of cysticercosis remains a major challenge. NCC is 
difficult to identify and treat as no diagnostic test identifies all cases of 
cysticercosis and also each test identifies a different group individual [23]. 
Diagnosis requires brain imaging, a technology commonly unavailable in 
resource-poor areas, and clinical diagnosis is unreliable, as the 
manifestations are diverse and non-specific [11]. 
          The pleomorphic manifestations of the disease and unpredictable 
response of the host to the cysticerci , make this an intriguing disease. 
Although theoretically easy to control and declared eradicatable, 
cysticercosis remains a neglected disease due to the lack of information 
and lack of awareness  of the burden of the disease in the endemic areas. 
World Health Organisation (WHO) has now declared cysticercosis as the 
“major neglected disease” [66].  
         India being a developing country, with large populations below the 
poverty line, neurocysticercosis is highly prevalent here. The disease is 
known to have existed in India for several years. A study done by Dixon 
and Lipscomb in 1961 , in 450 British soldiers who served in India , 

brought to light the latency of the disease and other features. But it did 
not draw attention to the disease burden in India. There is little 
epidemiological data on the prevalence of taeniasis , human or porcine 
cysticercosis  in India. Hence, in view of the burden of epilepsy patients  
in our country and the significant contribution of NCC to this , this 
present study was undertaken to estimate the seroprevalence of 
Neurocysticercosis among epilepsy patients in Chennai. 
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AIMS AND OBJECTIVES  
 
 
 To study the prevalence of anti cysticercus antibodies to T.solium 
in the serum of the  epilepsy patients 
 
 To estimate the proportion of  NCC cases in the epilepsy patients 
attending  our hospital. 
 
 To compare the efficacy of the  serological  and imaging methods 
in the diagnosis of Neurocysticercosis 
 
 To compare the efficacy of Enzyme linked immunosorbent assay    
(ELISA) and Enzyme immune sorbent assay  (EITB)  for the 
detection of anti-cysticercal antibodies to Taenia solium . 
 
 
  

REVIEW OF LITERATURE  
     Cysticercosis is the most common parasite of the Central Nervous 
System (CNS). It is caused by the larval stage of the tapeworm ,Taenia 
solium .The word cysticercus is derived from Greek word , ‘kystis’(cyst) 
and ‘kerkos’(tail) because of its appearance.77 
HISTORY 72: 
   Adult tapeworms were first recognized in human feces by the Egyptians 
which was probably, T.saginata. It was called by various names like 
‘flatworms’ as Hippocrates, Aristotle, Theophrastus called ,  meaning 
band or ribbon worm.  Whereas Romans named it ‘lumbricatus latus’ 
meaning broad or wide worm. The parasitc nature of the disease was 
demonstrated by Malphigi in 1697. The life cycle of T.solium was 
defined by Van Beneden who fed  a pig with eggs from human T.solium  
and found numerous cyst in the muscles. Aristotle and Aristophanes  
were the first to describe cysticercosis in pigs in 3rd century BC . Parunoli 
noticed it in humans in 1550. There has been  references to this disease in 
our ancient medical literature of ‘Charak Sanhita’. In India the disease 
was was first identified in Madras after the death of a patient due to 
seizure. On autopsy the patient was found to be infected with cystic stage 

of the parasite.  High rate of new onset epilepsy related to cysticercosis in 
the British army deployed in India has been described by Mac 
Arthur,1934 [32]. 
MORPHOLOGY & STRUCTURE : 
    Larval cestodes belong to the class Platyhelminthes, which are 
acoelomate metazoan with an elongated dorsoventrally flattened body  in 
adult stage and vesicular bladder in larval stage72 
Adult Worm : 
    It is a white, ribbon like, flattened , segmented worm measuring 2-
3metres  in length[71]. Body of adult worm is divided to head (scolex), 
neck and chain of segments (strobila). The head measures the size of 
pinhead and has four pairs of suckers and a rostellum with double crown 
of hooks.  
The characteristic feature of the morphology of the adult worm is that it 
lacks mouth or digestive cavity . The strobila is made of repeated units or 
proglottids , proximal segments being immature (lack developed sexual 
organs) and distal segments being mature (with fully developed sexual 
organs). The terminal segments are gravid and filled with nearly 30,000-
50,000 eggs and the uterus has 5-10 lateral branches. These gravid 

segments break off from the strobila and are passed in the faeces as chain 
of 5-6 segments.[72]  
Eggs : 
  The eggs are released from the gravid segments. They are spherical 
measuring 31-43µm in size and bile stained [10].The egg is surrounded by 
thin, outer transparent shell, which represents remnant of the yolk mass[3] 
. The oncosphere (embryo) is surrounded by the embryophere which  is 
formed by contiguous radial blocks, which  gives the radial appearance to 
the egg. The onchosphere  contains six hooklets ( hexacanth embryo) , 
measures 14-20µm and is infective to cattle and  humans[71]. 
     These eggs are similar in size and shape to those of T.saginata,  
Echinococcus and Multiceps. Hence these eggs cannot be differentiated 
by light microscopy [71] 
Cysticercus cellulosae (Taenia cyst): 
    It the larval form of T.solium and is infective form of the parasite to 
man. The cyst is a small , oval and fluid - filled  milky white bladder-like 
structure. It measures 3mm-15mm and appears translucent , the scolex 
seen as small , eccentric single dense white body [71]. The cysticercus has 

two chambers; the inner chamber containing the scolex with the spiral 
canal and the outer chamber containing the vesicular fluid, nearly 0.5ml . 
    Two morphological types of cysticerci are seen ; cellulose and 
racemose. The cellulose cysticerci are small, spherical or oval ,with 
vesicles measuring 0.5-1.5cm. The racemose cysticerci are large, round 
or lobulated with delicate walls. It measures  upto  10cm – 20cm and may 
contain 60ml of fluid. 
Life cycle [71]: 
     Definitive host : man  
     Intermediate host : pig , occasionally man 
        Man acquires infection by ingestion of undercooked pork infected 
with cysticerci. In the intestine the muscles are digested and the cysticerci 
released. The protoscolex evaginates and attaches to the intestinal wall 
with the help of suckers and hooklets. The adult worm develops from it, 
forming new segments at the caudal end .  The mature adult worm, which 
develops in  62-72 days , contains the fertilised egg. These eggs are 
released into the intestine intermittently , which is extruded in the faeces.  
        The pigs get infected by ingestion of the eggs or the gravid 
proglottid segments in the human faeces. The larvae hatch out of the eggs 

and attach to the intestinal mucosa. It invades the mucosa and vessel 
walls in 24-72hours, carried by the circulation to distant sites like muscle, 
brain etc. It develops into cysticercus form at these sites in 9weeks - 10 
weeks , remaining viable for upto 8 weeks. 
 
              Figure:1   LIFE CYCLE OF TAENIA SOLIUM 

 
        Occasionally humans become intermediate host by ingesting eggs 
present in the uncooked vegetables and contaminated water. The eggs 
develops in humans , just like in pigs and forms cyst. In humans, cysts are 
produced in the central nervous system, skeletal muscles, eye and 
subcutaneous tissues. Cellulose type is the most common in type in the 
human brain[72]. 
Transmission:  
               Humans become infested by the adult worm on  ingestion of raw 
or undercooked measly infected pork .Man becomes infested with the 
metacestode on ingestion of the eggs present in the contaminated drinking 
water, raw vegetables or from the stool of tapeworm careers [68]. Human 
to human transmission occurs under poor hygienic conditions when eggs 
from carriers contaminate the environment and food[36]. 
Pathogenesis & Pathology : 
   The adult worms are less pathogenic and remain asymptomatic. They 
cause minimal irritation and inflammation of the intestinal mucosa [71]. 
    The cysticerci are more pathogenic and  produce more serious disease 
called cysticercosis.  

 
Figure 2: Cysticerci 
(A): as seen in infected pork. (B): excised into a Petri dish. The white dot in each cyst 
corresponds to the scolex. (Courtesy:The LANCET, Vol 361) 
 
Different stages  of the  Taenia cyst   : 
              Morphologically , four stages of development and regression of 
the cysticercus in the CNS are recognized. 
i. Cystic or vesicular stage – viable cyst composed of well defined , 
fluid-filled membrane , containing scolex 
ii. Degenerating , colloid or Granular stage – corresponds  to parasite 
necrosis and associated inflammatory process. 
iii. Nodular stage characterised by fibrosis . This stage can be 
macroscopically identified as a nodule , smaller than the bladder in 
the preceding stage.  

iv. Calcified granuloma formed by the subsequent calcification of the 
nodule. The inactive calcified nodule develops within 5 years of 
infection. 
           In the brain, the cyst evolves through several stages of 
development.  In  the first stage there is intense inflammation surrounding 
the cyst as it migrates. The disease  remains mild or  inapparant in this 
stage .In the second stage the cyst secretes fluid and becomes fluid filled. 
The larvae develops within it over several weeks. The developing larva 
secrets a serine protease inhibitor and this favours the cyst from the 
evading the host immune response. In the third stage , the cyst becomes 
surrounded  by intense host inflammatory reaction. The larva degenerates 
and the cyst gets filled with caseous material. This stage is associated 
with a release of cyst contents and antigens into the cerebrospinal fluid 
(CSF) and serum. In the final stage, the cyst is replaced by fibrotic tissue 
which is followed by mineralization. This results in an inactive calcified 
nodule and develops in 5 years of infection.[34]  
 
Immune response[72] : 
          Anti cysticercus antibodies of several types have been detected but 
the most frequently found isotype being IgG  , subtype IgG2b, IgG2a and 

IgG1[28]. It has been detected in the CSF, serum and saliva . But IgG has 
not been detected in all compartments of the same patient. In the CSF 
IgM response has been frequently detected than IgG or IgA antibodies. 
These antibodies are not helpful in controlling the disease,  but protects 
the host from further re infection by the cysticerci[71]. The presence of 
IgG antibodies indicates the chronic and long term nature of the disease  .  
The antibodies produced are heterogeneous : As seen in Western blot  and 
immune electrophoresis in which upto 30 and 8 antigens have been 
recognised respectively. The humoral response is generally greater in 
patients with  multiple cyst than with single cyst infection. The intensity 
and duration of the disease directly correlates with the antibody 
production  [28]. 
Clinical manifestations : 
    Two distinct forms of infection caused by the adult worm and cyst are 
intestinal taeniasis and cysticercosis respectively. 
I.Taeniasis : 
      The adult tapeworm develops in humans after the consumption of 
infected pork . Taeniasis is characterised by mild symptoms or none at 
all. Abdominal pain, nausea and loss of body weight have been attributed 
to the tapeworm infestation.[71,28] Identification of these cases are 

important due to the risk of cysticercosis in the carriers and the immediate 
environment[28].   
II.Cysticercosis: 
    It is caused by infection with the larval stage of the parasite. Humans 
acquire the infection by feco-oral transmission  of the eggs from 
tapeworm carriers. Hence vegetarians and people who don’t consume 
pork can also acquire cysticercosis[28] .The clinical presentation of the 
disease depends on the location of the cysticerci, the ocular and neural 
cysticerci having greater morbidity. 
 a.Ocular cysticercosis : 
      Though less common than neurocysticercosis , ophthalmic 
cysticercosis accounts for 3% of cases. It the most common intra orbital 
parasitic infestation [28]. The cyst are found freely floating  in the vitreous,  
aqueous humour and sub retinal spaces[71,28]. The patient may present as 
iritis, palpebral conjunctivitis or uveitis.  Visual loss due the retinal 
detachment from  sub retinal cyst can also occur[71,28] .  Massive 
infections with the cyst may even present as proptosis [28] . Fundoscopic 
examination and orbital ultrasonography are non invasive methods which 
identifies the parasite [71,28].   

b.Neurocysticercosis (NCC) : 
       Neurocysticercosis (NCC) is the most severe form of the disease and 
accounts for 60-90% of the cases[71].  The clinical  manifestation is highly 
varied and depends on[71,28] 
1. The site of location, viability  of the cyst 
2. Type of cysticerci[32] 
3. Stage of development and involution of the parasite (sudarachnoid, 
intracerebral, intraventricular, intramedullary)[32] 
4. Number of the cyst 
5. Host immune response 
Two forms of neurocysticercosis are seen based on the location of the 
parasite  in the brain: parenchymal and extra parenchymal cyst. 

 Parenchymal disease occurs due to the infestation of the 
brain parenchyma with the cyst. This the most common 
form seen[32] 
 Extraparenchymal disease is caused by the cyst located 
within the ventricles , cisterns , sub arachnoid space or in 
the spinal cord[71].   

The most common site of location of the cyst is parenchymal followed 
by meninges, ventricles , eye and spinal cord[32].  
The presence of cyst is not always associated with symptoms. Although 
autopsy rates for neurocysticercosis in areas of high endemicity  
approaches to 2%, the majority of these cases have no symptoms 
attributable to the infection. It is only when the cyst degenerates and the 
host inflammatory response occurs, the patient manifests with symptoms 
like seizures. Therefore the symptoms in NCC may be delayed for several 
years or the patient remains asymptomatic [32]. Symptomatic NCC may 
present as follows:  
1.Convulsions and seizures : 
           Epileptic seizures are the common form of 
presentation[71,28,32,77].Seizures occur in 50-80%  of the patients with 
parenchymal brain cyst or calcification but is uncommon in other forms 
of the disease. In endemic areas , recent onset on seizures in a healthy 
young adult ,teenage or middle aged individuals strongly suggests NCC . 
Seizures, due to NCC, are  commonly generalized tonic, clonic or simple 
partial , few cases present with complex partial or myoclonic 
seizures[49,45,45]. About 50%  of these patients presenting with seizure , 
further develop seizure on follow up ( epilepsy) [28]. Some cysts escape 

the host immune response and remain asymptomatic (asymptomatic 
NCC) . This form is seen in the endemic areas and is caused by the cyst 
in the second stage of development[34,32].  
                 
2.Intracranial hypertension : 
     NCC can present with signs of raised intracranial pressure , 
hydrocephalus or both in 20-30% of the cases[28] . It is caused by the cyst 
located within the cerebral ventricles or basal cisterns causing obstruction 
to the flow of CSF by various mechanisms – obstruction caused by the 
parasite itself , ependymal inflammation or residual fibrosis. Headache , 
vertigo , and altered mental status are the presenting symptoms[71]. 
3.Meningitis : 
    Cysts of intra medullary spinal cord can produce motor or sensory 
disorders. 
4.Psychiatric manifestations : 
           Some patients may present with psychiatric manifestations 
detected by poor performance on neurological testing and severe 
dementia[51].  Psychotic episodes characterized by confusion, paranoid 
ideation, psychomotor agitation, and violent behaviour are other reported 
manifestations [30]. 
 

c. Subcutaneous cysticercosis : 
           It presents as small, painless , subcutaneous nodules most 
commonly located in  the arms and chest. After few years it becomes 
inflamed and painful followed by gradual resolution. Subcutaneous 
cysticercosis is commonly seen in Asia and Africa. 
 
Factors for transmission : 
         Increased consumption of pork and human migration has increased 
the spread of the disease from the endemic rural areas into urban areas. 
Livestock raising practices that allow free roaming of pigs is the greatest 
risk for pigs for acquiring cysticercosis[56]. Lack of environmental and 
personal hygiene, improper meat inspection , clandestine slaughtering of 
pigs are other factors favouring the transmission of the disease[55].  
 
 
 
 
 
 
 
 
 

 
EPIDEMIOLOGY          
 
FIGURE 3 : Map of areas affected by neurocysticercosis and cysticercosis . From the World 
Health Organisation (WHO)   , (Geneva, Switzerland)   
 
    Nearly 50 million people are known to be infected by Taenia  solium 
worldwide and it is  found more common in pork eating communities . 
The disease is more in developing countries with poor sanitation and 
hygiene and in developed countries with a higher rate of immigration 
from endemic areas[28] .  
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Global : 
            Taenia solium infection is endemic in Latin America,India,China , 
Eastern Europe and Sub Saharan Africa[71,51]  . Areas with highest 
prevalence include Latin America and Africa. In some regions in Mexico 
prevalence as high as 3.6% of the general population has been reported .  
Seroprevalence  ranging from 4.9%-24%[71] has been seen in Latin 
America. A WHO report says that the average prevalence of this disease 
in China is about 0.11%[18] . It has been estimated that nearly 1.26 million 
people live with taeniasis and about 3-6 million people with 
cysticercosis[18]. Epilepsy prevalence in SSA ranges from 5.2 to 74.4 per 
1,000 persons. Even developed countries like Canada and US report of 
cases of NCC , mainly due to the immigrant population[66] . In some 
regions like Guatemelia, Peru high seroprevalence of 39% have been 
reported in humans[46,18].  
India: 
             Cysticercosis has been designated as a “biological marker”of the 
social and economic development of a community. The disease is 
prevalent in all states of India, although the prevalence varies between the 
states. In India all biological and environmental factors , favourable for 
the transmission of T.solium exist.  Studies in endemic regions of India 
reveal high burdens of infection and symptomatic NCC[66].  

              In a community study in southern India, active epilepsy was 
present in 3.83/1,000 persons, and 28.4% of these individuals had NCC 
detected by CT imaging, the seroprevalence of T. solium infection was 
15.9%. Extrapolating these figures to the overall population in India 
suggests that approximately  1 million cases of epilepsy are due to NCC 
[59]
.  There are few reports of cysticercosis from Kashmir, which is largely 
populated by Muslims, and from Kerala, as education and hygienic 
standards are good in these state. In a study done at Bangalore, 
NIMHANS, nearly 2% of the epileptic patients studied reported diagnosis 
of NCC.  Between 26 and 50% of all Indian patients presenting with 
partial seizures are diagnosed with a SCG on the CT scan [40] . Another 
unusual feature is the low proportion of pork eaters amongst Indian 
patients , less than 1-2% of patients with NCC admits eating pork and 
more than 95% of Indian patients with NCC are vegetarians. Serological 
assays using the enzyme linked immunotransfer blot (EITB) has revealed 
exposure to the disease in 21.5% of 107 neurological patients attending a 
hospital in Mumbai[16]. Various studies have showed that the single cyst 
disease is the most common in India. In a study of 156 pathologically 
proven cases of cysticercosis from Patiala, Punjab, 88% patients 
presented with solitary lesion. In a seroprevalence study in Chandigarh, 
anti-cysticercus antibodies were found in 17.3%. In a community-based 

survey of population of 15,000 in a slum area in Ludhiana, Punjab, 114 
cases of active epilepsy were diagnosed and EITB assay was positive in 
27 of 106 cases with active epilepsy. In a community based study in 
Vellore district of South India the prevalence of NCC causing active 
epilepsy was found to be 1.3 per 1000 population. The results revealed 
high levels of exposure of the population to the parasite and a relatively 
high prevalence of active infections (4.5% antigen positives) but a low 
prevalence of NCC causing active epilepsy (0.13%). Cysticercosis 
seroprevalence among the healthy blood donors from Pondicherry was 
6.5% using both antigen and antibody detection methods.  
 
Diagnosis: 
        The diagnosis of NCC is made difficult due to its polymorphic 
clinical presentation. Criteria based on radiological, serological and 
epidemiological factors have been laid for the definitive and probable 
diagnosis  of  NCC ( Revised  Del Brutto criteria et al )   
 
 
 
 
 

 Revised diagnostic criteria for Neurocysticercosis   : 
Categories of criteria: 
Absolute criteria 
1. Histological demonstration of the parasite from brain or spinal cord 
lesion 
2. Cystic lesions showing scolex in brain by CT or MRI 
3. Direct visualization of the scolex in fundoscopic examination of 
the eye 
Major criteria 
1. Lesions highly suggestive of neurocysticercosis in neuroimaging 
studies 
2. Positive serum EITB  for the detection anti cysticercal antibodies  
3. Resolution of the intracranial cystic lesions after treatment with 
praziquantal or albendazole therapy 
4. Spontaneous resolution of the small , single enhancing lesions 
Minor criteria 
1. Lesions compatible with neurocysticercosis on neuroimaging 
studies 
2. Clinical manifestation suggestive of NCC 
3. Positive CSF ELISA for the detection of anti-cysticercal antibodies 

or cysticercal antigens  
4. Cysticercosis outside the CNS 
Epidemiological criteria  
1. Evidence of a household contact with T.solium infection 
2. Individuals coming from or living in areas where cysticercosis is 
endemic 
3. History of frequent travel to disease endemic areas 
 
Definitive : 1) one absolute; or two major + one minor + one 
epidemiologic. Probable: one major+ two minor; one major + one minor 
+ one epidemiologic; three minor + one epidemiologic  
 
   A finding of eosinophils in CSF indicates neurocysticercosis. But 
other routine diagnostic test are of little help in the diagnosis .Thus  
serology and neuro imaging form the main investigative techniques in 
diagnosing neurocysticercosis.[28] 
 
  

Serological techniques : 
A wide range of serological tests have been used in diagnostic and 
epidemiological studies of cysticercosis . But, most of these studies use 
the unfractionated antigens and so report high rates of false positive and 
false negative results[32] . Serology has mainly screening and 
confirmatory role and should be used in conjunction with neuroimaging 
for diagnosis[28]. A study done by Mahajan et al found that IHA test to be 
more sensitive and specific than CFT. On comparison with ELISA , IHT 
was found to be more specific for the detection of antibodies in CSF 
while cross reactions were observed with ELISA.[40] In another study  
from Pondicherry, South India, the co-agglutination test (Co-A) was 
moderately sensitive and specific for the diagnosis of cysticercosis.[16] 
These  tests are used for the diagnosis of NCC and for the 
epidemiological studies of NCC[71]. 
 
ELISA: 
IgG is the predominant antibody detected in patients with cysticercosis.; 
IgA,IgE and IgM antibodies are of little value in the diagnosis and cannot 
be correlated with the patient’s clinical condition[20]. ELISA can be used  
for the detection of antibodies in serum and CSF but detection of 
antibodies in CSF provides better reliability. The test has low sensitivity 

of 75% and moderate specificity of 85%. The major disadvantage in 
serodiagnosis using ELISA is cross reactions occurring in patients with 
coenurus , Echinococus , T.saginata, filariasis[72,28,20]. For this reason it is 
much more useful when applied to CSF than serum , with the drawback 
of pain and invasiveness associated with it. An ELISA for the detection 
antigens secreted by viable T.solium metacestodes used on CSF samples 
from Peruvian patients have demonstrated positive correlation between 
antigen levels and the number of live cysts detected by CT and EITB 
results[20]. Several methods based on ELISA have been established like 
DOT ELISA, Avidin- Biotin ELISA, dry blood paper ELISA and 
monoclonal antibody ELISA (MacAb-ELISA). All these newer methods 
show higher sensitivity and specificity. 
 
Enzyme Immuno Transfer Blot (EITB) : 
              EITB assay using purified fraction of glycoprotein (Gp) is highly 
specific (100%)  and sensitive (98%) for the detection of  antibodies both 
in CSF and serum[72,28,19]. The presence of 1-7 glycoprotein bands is 
considered to be diagnostic for T.solium infection[71].  The sensitivity of 
the test depends on the number of cyst : 98% sensitivity in three or more 
cysticerci and 65% sensitive for one or two cysticerci[19].Hence the assay 
is of limited value in children because  most of them have single 

lesion[72]. Although ELISA is most widely used test , EITB is gold 
standard in  serodiagnosis of  NCC  [19]. Both serum and CSF can be used 
as diagnostic specimens but it is more sensitive with serum than CSF[17] . 
But this assay require reagents , expensive equipments and trained 
personnel for antigen purification and assay performance than ELISA. 
      
        Antibody detection in cysticercosis has two major disadvantages: 
firstly it indicates only exposure to infection. It does not establish whether 
the patient is having established  and viable recent infection. Secondly the 
antibody continues to persist in the serum even after the parasite has been 
eliminated through immune mechanism or following drug therapy[12].  
 
        Detection of antigens  in serum or CSF indicates viable or active 
infection. Hence they have a role in therapeutic decision  and monitoring 
.Antigen can be detected in serum or CSF by ELISA using specific 
monoclonal antibodies . These antigen detection tests are highly sensitive 
and specific[71].  
 
Neuroimaging : 
         Because of the demonstration of important features like number, 
location and the stage of the cyst , imaging forms an important modality 
in the diagnosis of neurocysticercosis (NCC). Currently,CT and MRI are  

 
Figure : Neuroimaging 
MRI of viable (A) and degenerating (B) cysts, and CT of calcified cysticerci (C). 
(Courtesy: The LANCET, Vol 361) 
 
the major imaging techniques[28] . On neuroimaging four stages of cyst 
formation have been described. 
1. Vesicular stage – CT showing  hypodensity  containing a 
hyperintense small scolex along with nonenhancing or mildly 
enhancing cyst wall 
2. Colloidal vesicular stage – appears as ring enhancing cystic 
lesion with hypointense cyst wall and surrounding edema 
3. Granulomatous stage – cyst wall retracts and forms  
granulomatous nodule  appearing as enhancing  nodule with 
surrounding mild edema 
4. Calcified nodule – granulomatous lesion is shrunken and is 
completely calcified. Appears as single  or  multiple calcified 
nodule 
 

Computed tomography (CT) : 
              It demonstrates the cyst and granuloma stages of the parasite 
.These cysts are solitary or multiple and usually 5-20mm in diameter. 
These lesions are usually located in the cortex or grey white matter 
junction[34]. CT shows high sensitivity and specificity of  95% for the 
diagnosis of neurocysticercosis.  But CT images are rarely pathognomic 
for NCC[28]. The differential diagnosis of  cysticercus granuloma  is 
difficult because of the endemicity of neurocysticercosis and tuberculosis 
[28]
 . The disadvantage of CT scan is that it cannot differentiate the 
various stages of the cyst . Also the cysts located in intraventicular  and 
cisternal regions cannot be detected by CT scan[34,28]. CT is considered   
best for the demonstration of calcified stage[34] .  
 
Magnetic Resonance Imaging (MRI) : 
              MRI is the best imaging technique for the diagnosis of NCC due 
to its high sensitivity and its increased image resolution[34]. The 
degenerating and innocuous (viable) stages of the cyst can be better 
demonstrated by the parasite. The viability of the cyst can be established 
from MRI. The hypointense cystic lesions without the surrounding edema 
indicates viable cyst. Degenerating cyst is characterised by loss of the 
cyst fluid signal The number and stage of the cyst can be detected by 

MRI in contrast to CT scan[34]. It even detects the cysts located in the 
ventricle and cistern spaces. But the major drawback is the high cost and 
scarce availability [5] .  
 
Histopathogical diagnosis[2] : 
         Specific diagnosis of NCC can be made by the demonstration of 
cysticerci in biopsy obtained from the brain post-mortem. Skeletal 
cysticercosis can be diagnosed by demonstration of the parasite in the 
tissue obtained by biopsy or excision of the nodule.  
Prognosis and natural evolution: 
            The natural evolution of the intraparenchymal neurocysticercosis 
follows favourable outcome with degeneration of the parasite and 
formation of residual calcified scars .Cysts located in the sub arachnoid 
space have  high morbidity and mortality due to the parasite growth 
causing increased intracranial pressure , arachnoiditis, hydrocephalus  and 
other complications[28]. Seizure recurrence is high following the first 
acute symptomatic seizure related to the persistence of active brain 
lesions. Overall recurrence rate is 40% in one year[19].   Prognosis is best 
for those patients whom imaging study normalises . Seizure recurrence is 
reduced in patients with calcifications than those with active 
lesion[17.61.32]. 

 
Treatment : 
      The therapy of neurocysticercosis varies according to the clinical 
situation . Various factors that should be taken into consideration during 
the treatment of the disease include clinical symptoms, location and 
viability of the cyst, degree of neurological impairment, neuroimaging 
findings and host’s immune response[46 ] . Asymptomatic NCC with 
inactive calcified parenchymal NCC or degenerating cysts do not  require 
anti parasitic treatment. Anti convulsant therapy is required in these 
patient. Active parenchymal cysts are treated with specific anti parasitic 
drugs, albendazole being the drug of choice[24]. The dose of albendazole 
is 15mg/kg body weight given  in three divided  doses for 7 to 28 days. 
Corticoids is necessary for inflammatory clinical forms such as 
meningitis and occurrence with vasculitis. Surgical removal may be 
necessary for giant or racemose cysts and for those producing significant 
compression syndrome[25].       
               
Control of taeniasis and cysticercosis [2]: 
         The disease can only be reduced by improving sanitation and 
controlling domestic pig raising .Consumption of infected pork can be 
avoided by abattoir inspection and clandestine killing of infected pigs. 
Human taeniasis cases are important in terms of transmission. Hence, 

identifying and treating these population is important in the control of the 
disease. This can be achieved by the treatment of the tapeworm carriers 
or the whole population. Health education about the disease and its 
control by improved sanitation also contributes to the disease control.   
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MATERIALS & METHODS   
Type of study : A descriptive  cross sectional study type  
Period of study : August 2011 – September 2012 
Patient selection : 
       The study was conducted  among the patients attending the 
neurology clinic of  Stanley government medical college & hospital , 
Chennai for a period of one year from August 2011 to September 2012 . 
Patients with the complaints of seizure or epilepsy, attending  the 
neurology clinic as in-patients or out patients  were enrolled in the study. 
The study was explained in brief to them in their local language and 
informed consent obtained .   The study group included adult population 
aged  > 12 years , who came with complaint of  first episode of seizure    
( new onset seizure cases) and known epileptic patients who came for 
follow up (chronic epilepsy). 100 epilepsy patients were selected and 
serum samples were collected from them to detect the presence of 
antibodies to T.solium. 
  

Inclusion criteria: 
        Patients with complaints of seizure or epilepsy of both sex 
irrespective of the treatment . 
Exclusion criteria: 
      1. Cases of epilepsy from metabolic disorder 
      2. Alcohol withdrawal seizures.  
      3. Patients with epilepsy secondary to encephalitis or meningitis.  
      4. Post traumatic epilepsy  
Control population : 
 50 healthy blood donors  without complaints of  seizure /epilepsy or any 
such family history were enrolled as controls. 
Data collection: 
      Patient details were obtained from directly from the patients  
regarding area of residency , occupation . Each participant was 
interviewed with a questionnaire  to analyse the  various factors  that 
contribute to T.solium infection . Details regarding various potential risk 
factors like hygienic practices, sanitary conditions , pig rearing practices,  

travel to endemic countries, contact with known cases ( tapeworm 
carriers) were obtained . Clinical information  regarding the type of 
epilepsy, frequency , findings of physical examination , radiology  and 
MRI findings were obtained from the attending physicians and medical 
records. Our centre had MRI facility and most of the patients with 
complaints of seizure were investigated by this imaging technique by the 
clinician. 
Sample collection: 
    Stool samples were collected from the study group both from the in-
patients and out patients for the detection of T.solium eggs . freshly 
passed stool specimens were collected in wide mouthed, leak  proof 
containers . 3 stool specimen was collected from each patient. 
      3 ml of blood was collected from each patient  from venipuncture of 
the arm. The samples were centrifuged  and serum separated .The serum 
samples  were stored at -20°C until serological tests were done.  The 
serum samples were analysed for the presence of anti – cysticercus 
antibodies to T,solium  by ELISA and EITB . 
  

Sample Processing :  
Stool examination 
     Gross examination was done to note the colour , consistency , 
presence of blood /, adult worm or segments. 
Microscopic examination  of the feces was done by  saline and iodine 
mount to detect the ova. The stool samples were concentrated by formal 
ether sedimentation concentration technique . The sediments were 
examined by iodine and wet mounts to detect the presence of T. solium 
eggs . 
1. Saline wet  mount : 
• One drop of 0.85% NaCl was placed on a clean glass slide. 
A small amount of representative fecal specimen was picked 
up on an applicator stick and emulsified thoroughly 
• A 22X22 mm clean coverslip was placed over the 
suspension avoiding air bubbles 
• The eggs of Taenia were identified by following features: 
i. Spherical and brown coloured (bile stained) 
                   measuring 31-43µm  

ii. A thick outer transparent shell and inner embryophore 
which is brown , thick walled and radially striated 
iii. Onchosphere with 3 pairs of hooklets. 
2.Iodine wet mount : 
   Iodine wet mount was prepared similar to the saline wet mount , 
using D’Antoni’s iodine .   
 
Processing of Serum specimens : 
   The serum samples were detected for the presence of antibodies by 
ELISA and EITB. ELISA was performed with a commercial kit from 
SCIMEDX , USA. The confirmatory test ,EITB was performed at the 
department of Microbiology, JIPMER , Puducherry. 
 
 
 
 
 
 

ELISA  
 ELISA for the detection of antibodies to T.solium was done with a 
commercial kit from SCIMEDX corporation, USA. This tests was 
intended for the screening of serum IgG antibodies to T.solium .  The test  
was performed according to the instructions provided in the kit literature.   
 
 
Principle of the test : 
   The micro test wells were coated with T.solium cyst fluid antigen. 
During the first incubation period with the diluted patient’s sera , any 
antibodies reactive to the coated antigen bind to the coated wells. After 
washing to remove rest of the sample , the enzyme conjugate is added. If 
antibodies have been bound to the well, the enzyme conjugate will then 
bind to these antibodies. After another series of washes , a chromogen 
was added. If the enzyme conjugate was present , the peroxidase will 
catalyse the reaction  that consumes the peroxide and turns the 
chromogen from clear to blue. Addition of stop solution ends the reaction 
and turns the blue colour to a bright yellow colour. The reaction can be 
read visually or with an ELISA reader. 

Reagents: 
1. 96 titre microtitre wells coated with T.solium antigens 
2. Enzyme conjugate    - protein A conjugated to peroxidise 
3. Chromogen              - tetramethylbenzidine (TMB) 
4. Stop solution            - 0.73 M phosphoric acid 
5. Positive control        - diluted positive rabbit serum 
6. Negative control       - diluted negative human serum 
Preparation of Wash buffer : 
Removing the cap the contents of the bottle were added to 475 ml of 
reagent grade water. 
Washing  was done with ELISA washer which was set up appropriately. 
Preparation of the serum : 
Test samples : 5µl of serum was diluted with 315µl of dilution buffer. 
Dilution of 1:64 was prepared. 
Procedure : 
1. Wells were broken appropriate to the number of samples to be 
tested and placed in the strip holder. 
2. 100µl (2drops) of negative control was added to the well #1 

3. 100µl of positive control was added to the well #2 
4. Diluted test samples(patient’s serum ) was   to the rest of the wells 
100µl each. 
5. The microtitre plate was incubated at room temperature (15-25°C) 
for 10 minutes 
6. The contents were shaken out and washed 3 times with diluted 
wash buffer 
7. 2 drops of enzyme conjugate was added to each well 
8. Plate was incubated at room temperature for 5 minutes 
9. The plate was shaken to remove the contents and second washing 
was done 3 times with wash buffer 
10. To remove the excess moisture , the plated were slapped against 
paper towels 
11. 2 drops of chromogen was added to each well 
12. Plates incubated at room temperature for 5 minutes  drops of stop   
solution was added and mixed by tapping the strip holder. 
Reading of results : 
Results were read using  ELISA reader (Bio rad ,model 680 ) , set 
for bichromatic readings at 420/650 nm 
 

Quality control ; 
The validation of the kit was done with the controls provided. The 
values of the control were within the limits provided in the literature . 
Hence the kit was validated  and readings interpreted. 
             Negative – 0.0 to 0.3 OD units 
             Positive  -  0.5 OD units and above 
Interpretation of the results – ELISA  Reader 
Positive  - Absorbance reading equal to or greater than 0.3 OD units 
Negative - Absorbance value less than 0.3 OD units 
A positive OD reading indicates that the patient may be infected by 
T.solium or a closely related organism (eg.echinococcus) 
A negative OD reading indicates that the patient has no detectable 
level of antibodies. This may be due the lack of infection or poor immune 
response of the patient.  
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SODIUM DODECYL SULPHATE-POLYACRYLAMIDE  GEL 
ELECTROPHORESIS(SDS-PAGE)[61,39] 
      SDS-PAGE is indicated for analyzing the protein profile from the 
desired source,by characterizing and separating based on the molecular 
weight of the protein , in this case the antigen. 
Principle :  
            Electrophoresis is the migration of the charged molecules in 
solution in response to an electric field. In SDS-PAGE the 
polyacrylamide acts as the support matrix for the running sample.Sodium 
acrylamide sulphate is an anionic detergent which determines denatures 
the proteins by wrapping around the polypeptide backbone. The SDS 
confers negative charge to the polypeptide in proportion to the length. In 
denaturing SDS-PAGE seperations migration is determined by the 
molecular weight. 
Requirements : 
Reagents /Solutions : 
Stock solution  
1. 2M Tris-Hcl (pH8.8) -100ml 

2. 1M Tris –Hcl(pH6.8) -100ml 
3. 10%(w/s) SDS  
4. 50% (v/v) Glycerol-100ml 
5. 1%(w/v)Bromophenol blue-10ml  
6. TEMED-(N,N,N’,N- tetramethylene –ethylenediamine )  
7. 2-mercpatoethanol or Dithiothreitol 
8. Glycine  
Working solutions 
1. Acrylamide stock (30%)-100ml 
2. Separating gel buffer (4x)-100ml 
3. Stacking gel buffer (4x) 
4. 10% Ammonium per sulfate (APS)-5ml 
5. Electrophoresis / running buffer (1x)-1000ml 
6. Sample buffer -10ml 
7. Staining solution-1000ml 
8. Destaining solution -1000ml 
 
Procedure : 
10%  separation gel and 5% stacking gel were used. 

Sample preparation : 
 The glycoprotein antigens were prepared by using metacestodes 
obtained from the cyst fluid in the naturally infected pigs. 
The antigen (20µl) was mixed with the sample buffer (5µl) in an 
eppendorf and heated at 75-100°C for 2-10minutes . 
1. Clean glass slides were assembled by placing the spacers –two 
on either sides & one along the bottom edge &  the whole 
assembly was tightly with clamps . 
 
2. The glass plates assembled were sealed with melted wax on all 
three sides leaving the top side , so that the assembly is leak 
proof. 
 
3. The  casting gel were prepared with the components of the 
separating gel mixture without TEMED & deaerated.TEMED 
was finally added to the mixture and the gel immediately 
poured between the glass slides upto 2cm below the notch. The 
gel was allowed to polymerize for  30-60minutes at room 
temperature. 
 

4. The gel was overlaid with n-butanol which helps keep the gel 
surface flat. After polymerisation the butanol was removed and 
rinsed with water. 
 
5. The stacking gel was prepared and cast over the separating gel 
as mentioned above and the comb inserted. 
 
6. It was allowed to polymerize  for 15-20 minutes. Then the comb 
was removed carefully  and the wells rinsed with distilled water. 
 
7. The casted gel plate was removed from the gel casting stand 
/clamps and the  bottom spacer detached. The gel assembly was 
placed in the electrophoresis chamber with the notched plates 
facing the inside . The upper and lower tanks were filled with 
running buffer. 
 
8. The wells loaded with the antigen (10-50µl) diluted in sample 
buffer along with a molecular weight markers (5-10µl)  . 
 
9.  The electrophoresis was run at a constant current of 20mA till 
the dye front reached the separating gel and then increased to 
25mA. The run was stopped when the dye front reached the 

bottom of the gel.The side spacer were removed from the glass 
plates and carefully the gel scooped using the spatula .  
 
10. The gel was stained using the Coomassie staining solution for 
1-2 hours & then destained using the deataining solution for 
overnight in a rocking shaker. 
 
Results & interpretation : 
The bands separated according to the molecular weight were 
visualised directly and checked for the desired bands with the standard 
marker.  
The bands are transferred by blotting (Western) and confirmed by 
coupling with appropriate antisera containing complementary antibodies 
for the antigen.  
 
ENZYME IMMUNO TRANSFER BLOT (EITB) [12,27,73] 
Western blot or immunoblot (EITB) is the confirmatory test for 
diagnosing cysticercosis. Immunotransfer blot is the method used to 
detect a protein immobilized on a matrix. It is a method  for identification 

of a single protein in a complex mixture following separation based on its 
molecular weight , size and charge.  
Principle : 
The antigenic components are first separated by polyacrylamide 
gel electrophoresis .  The separated proteins are transferred from the 
polyacrylamide gel to a porous membrane and probing this with 
antibody.antigen antibody complex is then detected  using labelled anti-
immunoglobulin reagent .Antigens recognised by the antibody appears as 
bonds on the matrix and by comparison of these with the protein stained 
antigens allows the identification of antigens recognised by antibody. 
 
Procedure :  
Immunblottting is divided into two steps: Transfer of the protein 
from  the gel to the matrix and detection of the epitope with specific 
antibody. The protein transfer is achieved electrotransfer by semi-dry 
blotting technique. In this technique the gel - matrix is sandwiched 
between buffer –wetted filter papers through which current is applied for 
10-30 minutes. 
 

Requirements : 
Apparatus  
1.Electroblotting apparatus  
2.Power pack  
3.Rocker shaker 
4.Whattman 3MM paper (0.2µm) 
5.Nitrocellulose membrane (0.22µm) (BIOTRACE TM  NT 
nitrocellulose transfer membrane , PALL Corporation)  
6. Membrane holding forceps 
7. Containers for membrane processing 
 
 
 
1.Reagents and   Buffers : 
i. Transfer buffer 
ii. Phosphate buffered saline  
iii. Substrate buffer 
iv. Substrate buffer for horse radish peroxidise 
v. Antibody / conjugate dilution buffer 
vi. Washing buffer (PBS-T) 

2.Destaining solution 
3. Ponceau ‘s stain 
General assembly of the unit for transfer : 
1. The transfer buffer was prepared and equilibrated with acrylamide 
gel in buffer 20-60 minutes 
2.  Two pieces of pre-cut extra thick blot paper and pre-cut 
nitrocellulose membrane was saturated  in transfer buffer.  The 
transfer membrane was equilibrated  for atleast 10 minutes.  
3.  The safety cover  and stainless steel cathode assembly were 
removed 
4.  Pre-soaked sheet of extra thick filter paper was placed onto 
platinum anode. The surface of the filter was rolled out to remove 
air bubbles 
5. The pre-wetted blotting media was placed on top of the filter paper 
and air bubbles rolled out. 
6. The equilibrated gel is carefully placed on the top of the transfer 
membrane , aligning the gel on the centre of the membrane . 
7. The other sheet of pre-soaked filter paper strip was placed on top 
of the gel; and air bubbles between the gel and the filter paper 
carefully removed. 

8. The cathode is placed back on the stack. The latches were engaged 
with the guide post without disturbing the filter paper stack. The 
unit was plugged to the power supply and turned on. The transfer 
was run for 60-90minutes at 20V. 
9. Following the transfer , the antibody reactivity is visualised with a 
substrate solution   containing diaminobenzidine (6mg/ml in PBS 
containing 1ml of 30% of hydrogen peroxide) 
Immune detection :  
Blocking membrane 
1.10ml Blocking buffer was added (3% BSA in PBS 7.2) 
2. The filter paper was rocked gently for 30 minutes to 1 hour, so that the 
entire paper was in contact with the blocking buffer  
Wash membranes : 
The blocking solution is poured off and rinsed with PBS –T thice 
First antibody: 
1.Patients’s serum at appropriate dilution in 10ml of PBS-T  
2. Rocking was done gently for 1 hour in shaking incubator 

Wash membrane 
First antibody was poured off and washing was done with wash buffer (3 
times) 
Second antibody : 
The second antibody was added at appropriate dilution in 8ml 0.5% BSA 
TBS . Gentle rocking was done for 1 hour. 
Wash membrane 
The second antibody was poured off , rinsed for 30 minutes with PBS –T 
in 3 changes. 
Develop membrane 
1. The PBS-T was poured off from the membrane and then 
transferred into developing reagent  
2. It was rocked gently monitoring development 
3. The development was stopped by washing membrane with distilled 
water for 30minutes  in 3 changes 
Destaining  
1. The staining solution was poured off and sufficient destaining 
solution was added 

2. The filter was rocked gently till the bands were clearly visible and 
the background clear from the stain 
Interpretation : 
         The sample was considered reactive if it showed reactive bands to 
one or more glycoprotein antigens. 
 
Ethical consideration : 
The study protocol was submitted to the ethical committee of our 
institution. Ethical and research clearance was obtained  for the study on 
2011. With the permission from the HODs of the respective departments , 
the study was started . Informed consent was obtained from the patients 
before enrolling in the study. 
Statistical analysis : 
Statistical analysis was done with chi-square test or student t test 
where necessary. 
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RESULTS 
        About 100 cases , with complaints of epilepsy / seizure attending  
attending the Neurology department with complaints of seizures / 
epilepsy  and 50 healthy  controls without history of epilepsy were 
enrolled in the study , conducted during the period from August 2011 to 
September 2012 at the Department of Microbiology , Government 
Stanley Medical college ,Chennai.  . Blood  samples were collected from 
all the patients for testing for the presence of anti-cysticercus antibodies. 
The serum samples were processed by ELISA and EITB.  Of the 100 
epileptic patients enrolled , 48 patients submitted their stool specimen for 
examination .3 consecutive stool specimen was collected  from 14 cases  
and the rest were lost in consecutive follow up  and had submitted  single 
stool sample.  
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The results were analyzed as follows : 
                                                         Table -1 
                    Age distribution among the study and control groups : 
     
   Age  
 (years) 
       Study group             Control  group 
      No.          %           No. % 
     20  
 
       29       29             13 26 
     21-30 
 
33       33             16 32 
     31-40 
 
18       18             10 20 
     41-50 
 
12       12 7 14 
     51-60 
 
6 6 3 6 
      >60 
 
2 2 1 2 
     Total 
  
100 100 50 50 
Mean age 
±SD 
28.42±12.76 29.46±13.55 
   t-value 0.46 
        df 148 
P value 0.46 
  
             Most of the cases in the study group were in the age group of 21-
30 years with the mean age distribution of  28.42±12.76  years. In the 
control group also most of the patients were  in the age group between 
21-30 years with the mean age group of  29.46±13.55 years .  Hence the 
study group and the control  group are comparable. 
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                                                          Table -2  
        Gender distribution among the study and control groups : 
        Age  
     (years) 
            Study group 
              (n=100) 
          Control group 
                (n=50) 
 Male %  Female % Male (%)   Female (%) 
       20          13        16     8(16%)       5 (10%) 
      21-30 24        9     10(20%)       6(12%) 
      31-40 14         4     6(12%)       4(8%) 
      41-50 6         6     4(8%)       3(6%) 
      51-60 5          1    1(2%)       2(4%) 
        >60 2         0     1(2%)            0 
Total  64         36     30(60%) 
 
      20(40%) 
Male to 
female ratio  
1.8:1 1.5:1 
Chi square                      9.7                                        0.73 
       df  5 5 
P value                    0.24                                        0.73 
  
           The study group and control group were similar in the gender 
distribution with the male to female ratio in the study group being 1.8:1. 
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         Chart 1: Age distribution among the study population 
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     Chart 2:  Gender distribution among the study and control groups 
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                                              Table – 3 
Distribution of epilepsy according to the duration in the study group 
(n=100) : 
             Age  
          (years) 
       New onset             
        seizure(%)  
        (< 1 year ) 
          Chronic        
         epilepsy(%) 
             (>1 year) 
              20 18 15 
            21-30 10 21 
            31-40 6 11 
            41-50 2 8 
            >50 5 4 
            Total (%) 41 59 
  
New onset seizure was more common in  20 years age group while 
chronic epilepsy was common in the age group of 21-30 years.  
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                                               Chart -3 
Distribution of epilepsy according to the duration among the study 
population 
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                                               Table – 4 
         Various types of epilepsy among study group(n=100) : 
   
Type of epilepsy 
 
Number of patients 
among the study  
population 
  
   Percentage ( %) 
           GTCS 73 73 
             PS 27 27 
 GTCS- Generalised Tonic Clonic Seizures   PS- Partial seizures 
         GTCS was reported in 73% of cases and  partial seizures in 27%  
 
                                                       Table – 5 
 Gender  distribution of pork consumption in the study group and 
control group:                                                                                                                                   
             
     
Gender  
   
Vegetarians  
           Non vegetarians 
Total  Pork 
consuming 
     Non pork             
consuming 
Study group : n=100 
                
Male  
9 55 10 45 
              
Female  
11 25 8 17 
              
Total 
(%) 
 20 80 18 62 
Control group : n=50 
Mal e 8 22 3 19 
Female  4 16 1 15 
Total  12(24%) 38(76%) 4(8%) 34(68%) 
 
      In terms of the dietary habits, 20% of the study population were 
vegetarians and 80% non vegetarians of which   18% consumed pork and 
it was slightly seen more among  males than females. 8% of the control 
group consumed pork of which 3 (6%) were males and1(2%) female 
      Chart 4:  Various types of epilepsy in the study in the study group:  
                                                         
                                       
                                    
 
Chart 5: Consumption of pork in the study group:
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                                                        Table – 6 
             MRI findings in the  suspected cases of Neurocysticercosis             
(n=100) 
 
Age group 
   (years) 
No 
abnormality 
                 MRI findings 
  Total  Vesicular  
stage 
Colloidal 
vesicular 
Nodular 
calcified 
 20 24 6 3 3 0 
21-30 31 6 2 4 0 
31-40 13 1 0 1 0 
41-50 8 4 0 2 2 
>50 4 3 2 1 0 
Total  80 20 7 11 2 
Chi 
square 
13.4 
       Df 12 
P value 0.4 
                             
  
        Based on  the MRI findings of the study population  20% of  the 
cases were diagnosed /suspected to be NCC .  Colloidal vesicular 
suggestive  of  NCC was the common finding  seen  in 11% of the cases , 
found more in the age group of 21-30yrs. Nodular calcified stage was 
seen in 2 % in the age group of  41-50 years  
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MRI  FINDINGS IN THE STUDY GROUP : 
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                                                          Table – 7 
 Comparison of  the two groups from MRI 
i.e MRI suspected cases of NCC and normal study 
Characteristics    
   Category  
 
MRI  suspected 
cases  of 
NCC(%) 
           n = 20 
 
   Normal study  
             n = 80 
Age group <20 
21-30 
31-40 
41-50 
>50 
 6(30%) 
6(30%) 
1(5%) 
4(20%) 
3(15%) 
23(28.6%) 
27(33.8%) 
17(21.2%) 
8(10%) 
5(6.3%) 
Gender  Male    12(60%)        54(67.5%) 
Female  8(40%) 26(32.5%) 
Seizure type Partial  4(20%)        23(28.8%) 
Generalised 16(80%)         57(71.2%) 
Duration of 
seizure 
  1 year 10(50%)         40(50%) 
2-4 years 1(5%)         12(15%) 
5-9 years 1(5%) 10(12.5%) 
10 years 8(40%) 18(22.5%) 
                 
                    Majority of the epileptic patients with  lesions suggestive of 
neurocysticercosis in MRI  was found  in the age group <20 and 21-30 
years age groups , predominantly in males . Most of  them presented with 
generalised seizure  for less than a year.        
Stool microscopy for detection of  Taenia eggs: 
    Of the 150  patients , stool sample was obtained  from  68 cases i.e 48 
from  study group and 20 from control group.  Wet mount and iodine 
mount  was performed and following results obtained. 
  Of the 68 stool specimens  , Taenia egg was detected from none of the 
cases in study or the control group.   

                                                            Table -8 
 ELISA for the detection of anti-cysticercal antibodies to Taenia 
solium  : 
 
 
Age group 
   
 
No. of 
samples tested 
(n=92) 
   
   no.          % 
 
No of samples antibodies detected 
       
       
No of samples 
antibodies not 
detected  
 
 
 No .         % 
       
 
     Total  
   no       % 
    
 
    Male 
no.       %      
   
 
    Female 
no.        %  
<20   
          GTCS 
            PS 
   31 33.7   5 5.4 3 3.2   2 2.1   26 28.3 
    21 22.8 2 2.1 0 0   2 2.1   19 20.7 
   10 10.9 3 3.2 3 3.2   0 0      7 7.6 
21-30 
           GTCS 
        PS 
33 35.9 10 10.9 2 2.1   8 8.7   23    25 
26 28.3 8 8.7 3 3.2   5   5.4   18 19.7 
7 7.6 2 2.1 0 0   2 2.1     5 5.4 
31-40  
          GTCS 
       PS 
12 13   4 4.3 3 3.2   1 1    8     8.7 
9 9.8 2 2.1 2 2.1   0 0     7 7.6 
3 3.2 2 2.1 2 2.1   0 0     1 1 
 41-50 
           GTCS 
       PS 
13 14.1   2 2.1   1 1   1 1   11 12 
12 13 1 1 1 1   0 0    10 10.9 
1 1 0 0 0 0   0 0     1 1 
  >50  
          GTCS 
       PS 
3 3.2   2 2.15 2 2.1   0 0    1 1 
2 2.1 2 2.1 2 2.1   1 1    0 0 
1 1 0 0 0 0   0 0     1 1 
    Total  92 23 25  11 12 12 13    69 75 
Chi square  6.10 2.80 
         df 4 3 
P value 0.19 0.59 
  
  
  ELISA  detected antibodies in 25% of the serum samples 12% of males 
and 13% females among the epilepsy patients. Of this  highest 
seroprevalence  of antibodies i.e 10.9% was seen in the age group 21-30 
years and 8.9%  presented with GTCS. There is no significant difference 
in the seropositivity between males and females(p >0.05) 
  
                                    Chart 7: 
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SDS –PAGE AND EITB: 
     Analysis of the whole cyst antigen after seperation by SDS –PAGE 
revealed distinct protein bands of molecular weights ranging from 
106kDa to 10kDa. The major antigenic peptides were found to be 76kDa, 
68 kDa, 40 kDa, 32kDa,24 kDa and 18 Kda. On immunoblotting with 
sera from the patients showed reactivity at 40kDa and 24kDa bands. 
    
                                                    Table-9 
     Enzyme Immuno Transfer Blot (EITB) for detection of antibodies 
to Taenia solium: 
           Age    EITB      reactive             % 
 Epileptic 
patients n=100 
          27 27 
 Healthy controls  
n=50 
3 6 
  
 
               EITB detected antibodies  to larval stage of  T.solium in 27% of  
the epileptic cases. 6% of the control population were reactive. There  is 
significant association of the epilepsy with the presence of anti-
cysticercus antibodies in the serum. 
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                                                 Table - 10 
       Distribution of Age , gender , seizure type  and duration among 
the seropositives (n=27): 
 
Characteristics 
  
 Category  
 
   EITB 
    n=27 
       
   P value 
 
Age group <20 
21-30 
31-40 
41-50 
>50 
   7(25.9%) 
  12(44.4%) 
   3(11.1%) 
   3(11.1%) 
   2(7.4%) 
 
 
0.99 
Gender  Male      12(44.4%) 0.811 
Female     15(55.6%) 
Seizure type Partial      9(33.3%)  
0.36 Generalised   18(66.7%) 
Duration of 
seizure 
  1 year    12(44.4%)  
 
  0.26 
2-4 years     6(22.25) 
5-9 years     4(14.8%) 
10 years     5(18.5%) 
MRI  Suspected 
NCC cases 
8(29.9%) 0.6 
 
               The comprehensive clinical details of  the antibody positive 
cases  is given in the above table. The presence of antibodies detected by 
EITB was high in the age group of 21-30 years  . EITB tested slightly 
more positives in females (55.6%) than males (44.4%) , the male to 
female ratio being 1: 1.3 and it was not statistically significant (p>0.05). 
Generalised tonic clonic seizures was detected among 66.7% of  the cases 
in which antibody was detected. Antibodies were detected more in the 
cases presenting with seizures for less than  1 year duration.  
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                                                      Table - 11 
         Association of potential risk factors and the seropositivity  by 
EITB:  
      Risk factors  
 
 
Seropositive  
  
Seronegative 
  p value 
Pork consumption           
n=18 
13(72.2%) 5(27.8%)  
0.07 
Lack of personal 
hygiene & toilet 
facilities 
n=45 
 20(44.4%) 25(55.6%) 
 
 Analysis of the distribution of the potential risk factors 
between the seropositive and seronegative groups, showed that  about 
72.2% of the  pork consuming  population  had antibodies to T.solium . 
Among those with poor toilet facilities, antibodies were detected in 
44.4%. 
                                                        
                                                         Table - 12 
                             Comparison of the imaging and serology results : 
            EITB     MRI suspected 
cases                    
             of  NCC 
(n=20) 
    MRI without           
       Abnormality(n=80) 
Antibodies present 10(50%) 17(21.3%) 
Antibodies absent 10(50%)  63(78.6%) 
 
  On comparison of the imaging and serology results by EITB ,50% 
of the cases who  had imaging findings suggestive of NCC were reactive 
in EITB. Of the patients with normal imaging study , antibodies were 
detected in 21.3% .    
     

                                             Table – 13 
      Comparison of ELISA positives (n=23) and EITB positives                     
(n=27) 
      Both 
EITB&ELISA 
positive 
   EITB only 
positive 
  ELISA only 
positive 
No of samples     17 10 6 
   
In 17 cases antibodies were detected by both ELISA and EITB . In 
10 cases antibodies were detected by EITB only .  False positivity of  
ELISA was seen in 6 cases.  
 
                                                       Table-14 
             Sensitivity and specificity of ELISA in comparison to EITB 
           Sensitivity  61.5% 
           Specificity  90.4% 
               PPV 66.67% 
               NPV 89.19% 
 PPV-Positive Predictive Value   
                      NPV- Negative Predictive value  
        Taking EITB as the standard, ELISA  showed sensitivity of 61.5% 
and specificity of 90.4%.   
 
 
 
 
 

Based on the radiological and serological findings , applying the Del 
Brutto et al criteria for the diagnosing neurocysticercosis, 8 cases of NCC 
was identified -  4 definite and 4 probable cases. The clinical details of 
these patients is given in the following table. 
                                                   
                                                   Table – 15 
Definite and probable cases of NCC based on Del Brutto’s  criteria 
(2001) 
GS- generalised seizure    REL- ring enhancing lesion 
 The definite and probable cases of NCC were in the age between 15-45 
years, males slightly more than females. In the definite cases of NCC , 
most presented with new onset , generalised seizures. Pork consumption 
was found in 3 of the 4 definite cases. Solitary granuloma was the most 
common MRI finding in these cases. 
  
No.  Age 
/sex  
Onset of 
seizure 
Duration  Type of 
seizure 
Pork 
consumption 
     MRI Antibodies    
EITB  
Definite cases 
1. 42/M New 
onset  
    3 days     GS        yes Granuloma Present  
2. 21/F New 
onset  
   16 days     GS         no Granuloma Present  
3. 26/F New 
onset 
    6 mon     GS yes Multiple     
    REL 
Present  
4. 17/m Chronic     2 years     GS yes Granuloma Present  
Probable cases 
1. 15/m New 
onset 
4 months    GS no Granuloma      Present 
2. 22/M Chronic  3 years    GS no Granuloma     present 
3. 50/m Chronic  3 years    GS yes Granuloma     Present  
        
4. 25/f Chronic  12 years     GS no Granuloma Present  

Discussion : 
          Epilepsy due to neurocysticercosis (NCC) is a major public health 
problem especially in developing countries. Nearly one third of the active 
epilepsy is due to NCC  in the developing countries. A high proportion of 
patients with late-onset epilepsy, especially in endemic regions like Latin 
America, has been attributed to this  aetiology[28,32]. In India many factors 
favourable for the transmission of the disease exists like low 
socioeconomic status, poor hygienic practices , pig rearing. But there is 
very little data on the prevalence of the disease in the general population 
or among epilepsy patients. The diagnosis of this disease is a major 
challenge as it presents with non specific clinical manifestations. Hence 
for the diagnosis and treatment of epilepsy due to NCC , knowledge of 
the prevalence of the disease in that region  and  a high index of suspicion  
is essential. Hence the present study was done with the objective to assess 
the seroprevalence and prevent  the transmission of the Taenia solium  in 
the population .  
          The population enrolled in this study included patients seeking 
medical attention and care for seizure or epilepsy , which included new 
onset seizure and chronic epilepsy patients, at Stanley hospital, Chennai. 
The control population included healthy individuals without complaints 

of seizure or epilepsy . The 150 patients enrolled in the study were 
residents of Tamilnadu, coming from various areas in and around north 
Chennai. Detection of antibodies only in the serum   was chosen , because 
lumbar puncture for the collection of CSF would be invasive and 
unethical unless indicated. Antibody detection in the serum by EITB was 
done both in the study and control population. We were able to perform 
ELISA only in the study group due to the unavailability of the kit at that 
time.     
 
Age wise distribution of the epilepsy patients : 
        The study  group included patients aged 13-64 years with the mean 
age of 28.42±12.76 years. In the present study epilepsy was seen in all 
age groups in the adult population , the majority of patients were in the 
age group of 21-30 years (33%) followed by <20 years age i.e 29% 
(Table1). In a study done by Goni et al [24](1962) majority of the cases 
were in the age group 20-40 years . A study done by Kuruvilla et al[58] 
(2001) at a tertiary care hospital in Kerala, reported age range of 24-35 
years with mean age of 35.2 years. The age distribution of the epilepsy 
patients in the present study is similar to results of the above studies. 

Gender distribution among epilepsy patients : 
Of the 100 epileptic seizure patients studied , 64% were males and 36% 
were females with male to female ratio of 1.8:1 (Table2). Similar 
distribution  was seen in a study  by Parija et al [53](2011)  in which males 
were 60.8% of the epileptic seizure patients studied.  
Seizure pattern seen in the study population : 
    Humberto et al  studied neurocysticercosis and epilepsy in Africa , and 
found  that generalised seizures was reported  slightly more often than 
partial seizures. Of the generalised seizures, tonic clonic type was the 
most often reported. In his study , among the patients with epilepsy , 
seizures within past year was seen in 28.9% and seizure for than 10 years 
was seen in 31.2% In our study, among the 100 epileptic patients about 
41% presented with seizure duration of less than 1 year (new onset 
seizure). The majority of these patients belonged to < 20 years (Table3) . 
Chronic epilepsy constituted 59% of the study population with the highest 
number in the 21-30 years age group.The most common  seizure type in 
this group  was generalised tonic clonic seizure (GTCS) seen in 73% of 
the study population (table4). Partial type of seizure was seen in 27% of 
the patients. The results obtained in our study is similar to the above 
study.  

Pork consumption and other potential risk factors among the study 
group : 
      In the present study , only 18% of the study group and 8% of the 
control group gave history of consumption of pork (table 5). This is less 
than that reported by Kuruvilla et al [37], who reported 36% of pork 
consumption among his study group . The low percentage of pork 
consuming population in the present study is due to the dietary habits of  
the people in this region. Nearly 45% of the cases in the study group 
reported absence of sanitary infrastructure. This results in open areas and 
field defecation. Free roaming pigs have access to these human feces and 
perpetuate the transmission of the parasite from pigs to humans. 
MRI findings : 
When MRI was used to identify cases  , about 20% of the epileptic 
patients were diagnosed as NCC. (table 6). Nodular Calcificied 
inactive lesions were detected in only 2% of the cases in the 
present study. However colloidal vesicular stage presenting as 
granuloma  was the most common lesion in MRI  identified 
constituting 11% among the epileptics , 55% of the  suspected 
NCC cases.   Similar results were shown in a meta analysis by 

Rajasekhar et al [54] , who reported that 60-70% of NCC cases in 
India present as solitary cystic granuloma. Mohanty et al[55] studied 
NCC prevalence in a north Indian hospital showed solitary 
granuloma to be the common radiological finding seen in 74.2% .  . 
Of the radiologically suspected cases , nearly 60% of the cases 
were less than 30 years. Kotokey et al has reported that maximum 
incidence of neurocysticercosis in 21-30 years , seizures being the 
common presentation. The findings of our study correlates with 
findings of the above study. 
Stool examination :  
           Of the 100 cases in the study group , stool sample was obtained 
from 48 cases . Taenia egg was not detected  in any of these 
specimens tested. This may be because of the small number of 
specimens examined. A similar study done by Ashish et al[4] 
demonstrated Taenia eggs in 21.2% of the patients with multiple 
CNS lesion and 9.1% with solitary lesion in CNS. Similar study  in 
the future with larger number of cases included  might throw light 
on the prevalence of intestinal taeniasis .   
 
 

Antibody   detection by ELISA in epilepsy patients: 
      The diagnosis of neurocysticercosis is difficult as the sensitivity and 
specificity of the test depends on the clinical stage of the disease. Imaging 
techniques like CT and MRI provide quicker results but not available in 
low income settings. MRI has the advantage of detection of the various  
stages of the parasite. However it is expensive and not available in many 
hospitals. Serological tests available for antibody detection include 
ELISA and EITB. 
      ELISA has been shown to have variable sensitivities by various 
authors. It has added disadvantage of significant cross reactions with 
other cestode infections like hydatidosis[71,72] . In the present study, anti-
cysticercal antibodies were detected in 25% of patients with epilepsy by 
ELISA (Table 8). Parija et al[24] who has done a similar study detected 
antibodies in 17.45% of the epilepsy population.In our study, antibodies 
to cysticercus of T. solium detected by ELISA was more in the age group 
of 21-30 years and majority presented with GTCS (table 8). Of the 23 
seropositives, 11 were males ( 47.8%) and 12 females (56.5%)  .No 
difference in the seropostivity between the two sex was identified. The 
above mentioned study done by Parija et al [24]  reported that ELISA was 
positive in 56.44% of males and 43.56% of the females in the study 
population showing more seropositivity in males than females. 

Results of EITB : 
  Seropositivity among the study population : 
     The study population was tested for anti-cysticercal antibodies by 
ELISA and EITB.EITB being the confirmatory serological test for 
cysticercosis, the seroprevalence was estimated based on its results. In the 
present study seropositivity  among the epilepsy patients  for IgG anti-
cysticercal antibodies was  27%. This should be interpreted with caution 
as the study population was patients volunteering for medical care  and 
not randomly selected. Hence at the community level the seropositivity 
may be still higher. 
Other similar studies were, 
 Author    % Prevalence 
Present study  27% 
Ashish kumar et al[4]  32% 
Kishore L et al [34] , 2004 35.9% 
Kashi N Prasad et al (2009)[31] ,Lucknow north 
India 
48.3% 
Parija et al[24], Pondicherry(2010) 16.2% 
V Rajasekar et al[43], Vellore district, India(2006) 13% 

Basem et al ; (2010) 6.5% 
L. Guillermo Palacio[42] et al, Columbia (1998) 9.82% 
Mittal V et al[56] ,India (2001 )  10.1% 
Oscar H. Del Brutto[61] et al, Ecuador, 2004 8.6% 
 
The seroprevalence obtained in our  study is  higher than previous studies 
done in South India. The high seroprevalence in this region may be due to 
the fact that most of the cases included were from areas in and out of 
North Chennai. Majority of the people living in this region , are below 
poverty line with low socioeconomic status , low sanitation and poor 
hygiene. Cysticercosis , said to be the b`iological marker’  of social and 
economic status of a region, well relates to the high seroprevalence in this 
region.   
        EITB is more specific than ELISA  as the latter uses  crude antigen 
for antibody detection . Whereas in EITB  the crude antigen is seperated 
to the various glycoproteins which is then blotted on to a membrane. The 
antibody reacting to these specific antigens appears as bands. 
  In our study , antibodies to T.solium was detected in 27% of the 
epileptic population (table 9).  Studies done in the various parts of the 
country have reported various seroprevalence rates. A community study 

done at rural Honduras by Sanchez L et al [62] showed seroprevalence of 
17%. A similar study done by Parija et al[53] reported anti-cysticercus 
antibodies in 16.2% of the epileptic patients studied. Mohanty et al 
reported anti-cysticercus antibodies in 14.1% of the neurocysticercosis in 
north India[44] .  Seroprevalence of 35.9% was reported in Aurangabad by 
Kishore et al [34] among clinically suspected and MRI proven cases of 
neurocysticercosis. Previous studies conducted at Chandigarh [33], 
antibodies were detected in 17.4% to 29.2% of the epileptic patients..  In 
1998,    Ahuja et al [6]demonstrated antibodies in nearly 30% of the 
epileptic patients. Similar   studies  done in the epileptics  around the 
various parts of the world have shown prevalence rates of 12% in Peru[26] 
(1993) , 44.6% in Cameroon[2], 10.8% in Morelos, Mexico [65].  
             Among the healthy controls tested , antibodies were detected in 
6%. A similar study done at Vellore[62], South India , showed the 
seroprevalence of antibodies  to T.solium in the seizure free study groups 
to be  15.9% .  
In our study, the reactive samples showed antigen –antibody reactivity at 
the 40kDa and 24Kda band regions. This is similar to the bands patterns 
obtained by Parija et al  who showed reactivity at 40kDa, 32kDa, 24kDa , 
18 kDa regions [53] and Bucardo et al who found reactive bands frequently 
in 50kDa, 42-39kDa , 24kDa and 14 kDa regions. 

Analysis of the seropositives by EITB   (table 10): 
    Age : In this study , antibodies to T.solium was detected in all age 
groups , but the major distribution was found between 21-30 years.  
Community based  studies like S arti et al  have demonstrated  increasing 
trend of seropositivity with increasing age peaking at 46-55 years. Such 
pattern of seropositivity was not detected in the present study as the study 
population had more cases < 30 years than  >40 years.  
Sex :  Antibodies were detected slightly more in females (55.6%) than 
males (44.4%) but it was not statistically significant (p > 0.05). Most of 
the previous studies[24,4] have showed no significant association between  
seropositivity and gender  which is similar to the findings of the present 
study. 
Seizure type : Generalised seizure was the most common type of seizure 
observed. Ashish kumar et al [4] and Bucardo et al have also reported that  
generalised seizures is the most common seizure type seen in NCC cases. 
 
 Association of potential risk factors with the seropositivity: 
        About 72.2% of the pork eating population were detected of anti-
cysticercal antibodies in the serum .In a study done by    Blocher J et al[7]  
showed significant association with pork consumption and  risk  for NCC 

. In this context it is to be stressed that cysticercosis is a feco-oral 
infestation and pork consumption is not a prerequisite. The  high 
proportion of seropositivity in the pork consuming population indicates  
exposure to the T.solium eggs. This could be due to the autoinfection of 
the eggs from  these cases by feco oral transmission or reverse 
peristalsis[71]. Pork consumption may be indirectly   associated with 
exposure to the parasite, due to the presence of family members  
consuming  pork , who  may be tape worm carriers and may be a potential 
risk factor for the disease . 
Comparison of the imaging and serology results : 
                       Of the 20 radiologically suspected cases of NCC , 
antibodies to T.solium was detected  by EITB in only 10 of them and the  
rest  non reactive .(table 12). This can be because of the misdiagnosis by 
MRI of some cases and failure to differentiate from other differential 
diagnosis with similar radiological finding like tuberculoma. It was 
observed in the present study that only 29.9% of the cases reactive by 
EITB had MRI lesions suspective of NCC (table . 10)In about 17(21.3%) 
cases, though imaging showed no abnormality , antibodies were 
detected.This can be due to EITB detecting antibodies in patients with 
cysticerci in  parts other than CNS  also and the antibodies persisting after 
the disease is cured . This proportion is slightly lower  than the 27% 

detected by EITB . Similar studies done by Mohanty et al [44]  and 
Guillerma et al [38]  showed a higher proportion of cases detected by 
imaging than serology. In these studies , CT was used as the imaging 
modality for diagnosis. This may be the reason for the lower detection of 
NCC cases by MRI in the present study . In the later stages of the 
development of the cysticerci in the brain, it undergoes calcification.Such  
parenchymal calcifications are better visualised in CT than MRI 
 
Comparison of ELISA and EITB : 
              Of the 23 samples positive by ELISA, 17 samples were found 
reactive by EITB (table 13). Taking the EITB as the gold standard test , 
the sensitivity of ELISA was 61.5% and specificity of 90.4% (table 14). 
False positivity was seen in 6 cases (Table 13). Kotokey RK et al , 2006 
demonstrated  that ELISA had sensitivity and specificity of 82.6% and 
100% in definitive NCC cases and 78.3% in CT suspected cases. In a 
similar study done by  Parija et al[53] at JIPMER , Puducherry  ELISA 
showed low sensitivity of 91% and high specificity of 98%.  Palacio et 
al[52] (1996) who studied the prevalence of NCC in epilepsy patients, 
showed ELISA had a sensitivity and specificity of 27% and 100% 
respectively. The above studies show that ELISA has variable sensitivity 
and specificity. False positives were detected in 6  cases.  In our study 

ELISA was found to have low sensitivity but high specificity. The low 
sensitivity of ELISA  is due to the crude antigen used for the detection of 
antibodies. The complex conformation of these antigens stays 
inaccessible to the antibodies [48].The high false positives is due to the  
cross reactions with other infections like hydatid disease. Hence a 
positive result needs further confirmation with EITB. Western blotting 
though reported with high sensitivity and specificity has disadvantages. It 
is costly , requires expensive equipments, time consuming  and hence it 
as not available in most of the health care settings.On the other hand,  
ELISA is rapid, easy to perform, cost effective and many samples can be 
processed . Hence ELISA can be used in community studies to assess the 
seroprevalence .  
 
Proportion  NCC cases causing active epilepsy: 
             The serological tests detecting for the presence of antibodies to 
T.solium can only assess the exposure to the parasite and its transmission 
in the community. Presence of these antibodies indicate the past or 
current  exposure / infection  to T.solium but not the presence of the 
disease . The lesions of NCC in   imaging techniques  like CT or MRI 
needs to be differentiated from other etiologies especially tuberculoma. 

Hence  the diagnosis of the disease status of the individual requires both 
imaging and serology findings .  
       In the present study, based on the modified Del Brutto’ s criteria 
diagnosis of neurocysticercosis was made in 8(8%) cases-  4 definite and 
4 probable cases. (table 15) 
Definite :  major criteria – a) lesions suggestive of NCC in MRI and 
                                        b) positive serum EITB 
                                            and 
                minor criteria – Suggestive clinical feature (epileptic patients) 
                                            and 
                epidemiological criteria- patients living in highly endemic areas 
 
Probable :   1major criteria : positive serum EITB  
                                            and           
 2 minor  criteria: a) lesions compatible with NCC on MRI and 
                            b) suggestive clinical feature (epilepsy) 
        In the present study the seroprevalence of the antibodies to T.solium 
was 27% by EITB and active NCC was seen in 8% of the epilepsy 
patient. Hence  though there is high exposure to T.solium in this 
population , the proportion of active NCC cases causing  epilepsy is 
lower. 

SUMMARY : 
   Patients presenting with seizures or epilepsy , attending the neurology 
department as in-patients or out patients were enrolled  and the study was 
conducted. All the  cases were made to answer a questionnaire  designed 
to assess the potential  risk factors . After  clinical and neurological 
evaluation , imaging by  MRI was done in them . Serum samples were 
collected from 50 healthy individuals without complains of epilepsy as 
control population. Serum samples were collected and tested for the 
presence of anti-cysticercal antibodies to T.solium by ELISA and EITB. 
              In the present study, of the 100 cases  following results were 
obtained 
• Majority  i.e 30% of the  epilepsy  cases were seen in the age 
group of 21-29 years and the males to female ratio  was 1.8:1.  
• Chronic epilepsy (> 1 year ) was reported in 57% which is 
slightly more than that of  incident seizures . 
• Generalised seizure was the most common seizure type observed. 
•   Of the 100 epileptic patients studied, radiological diagnosis by 
MRI  suspective of NCC was made in 20 cases. 

•  Colliodal vesicular stage as  seen as granuloma was the most 
common lesion observed in MRI followed by ring enhancing 
lesions. 
• Seroprevalence of anti cysticercal antibodies to T.solium   was  
found to be 27% by EITB  and in 6% of the control population.  
• Majority of the seropositives were in the age group of 21-30 years 
, females slighltly more than males.  
• Generalised seizure was the most common type observed among 
the seropositives.  
• Antibodies were detected  more in the new onset seizure group 
than that seen in the chronic epileptic patients.  
• Consumption of pork was seen in 72.2% of the cases with anti-
cysticercal  antibodies 
• Antibodies were detected in only 25% of the  cases by ELISA.  
• Taking EITB as the standard test, the sensitivity and specificity of 
ELISA was found to be 61.5% and 90.4% respectively .  False 
positivity was seen in 30.4% of the cases.  
• On comparing imaging and the serology findings , anti-cysticercal 
antibodies were detected in 50% of the radiologically suspected 

NCC cases. Antibodies were present in 21.3% of the cases with 
normal imaging study 
•  
 Based on the modified Del H Brutto’ s criteria , definite and 
probable diagnosis of NCC was made in 4 and 4 cases 
respectively.  
                
 
 
 
 
 
 
 
 
 
  

CONCLUSION : 
       Epilepsy is an important public health problem in developing 
countries like our country with the significant impact in the economy of 
the country . Neurocysticercosis is an important cause of acquired 
epilepsy contributing to nearly one third of the epileptic cases in 
developing countries.  From the present study we conclude that the there 
is high  level of antibodies to cysticercus of Taenia solium . Hence 
indicating the high level of exposure to Taenia solium in the  epileptic 
population studied . Though there is high level of exposure to the 
parasite, the proportion of active disease  due to NCC was lower in the 
epilepsy patients studied. Epilepsy is the predominant  manifestation of  
NCC in our subcontinent. The  study also shows that serological tests like 
ELISA and EITB aid in the better  identification of  clinically and 
radiologically suspected active  NCC cases.  ELISA has low sensitivity  
and high specificity  than EITB in detecting the antibodies. But the lower 
cost and rapid results obtained  makes it the serological test of choice in 
developing countries . The positive results requiring further confirmation 
with EITB.  Overall the results of this study shows that there is rising 
trend of NCC and its seroprevalence in the epileptic patients. Hence  
NCC is a growing public health problem in our country and there is need 
to control  this disease by proper  sanitation and hygiene .  

APPENDIX  I: 
Reagents  required for ELISA : 
• Microtitre plates coated with  T.solium antigen 
• Sample dilution buffer 
• Wash buffer,Phosphate buffered saline (NaCl) solution (10 fold 
concemtrate) 
• Positive control ( diluted positive rabbit serum )                   
• Conjugate – Protein A conjugated with peroxidise 
• Substrate : tetra methyl benzidine(TMB) 
• Stop solution : 0.75M phosphoric acid 
• Distilled /deionised water 
• Distilled water 
• Test tubes 
• Disposable pipettes 
• Vortex mixer 
• Micropipette for 50-100µl and 1ml volume 
• Stop clock  
• Washing unit for microtitre plates or multi channel pippetes 
• Photometer for microwell plates (450nm and reference filter  
600nm ) 
• Filter paper(laboratory towels) 
• Waste container containing 0.5% hypochlorite solution 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
Appendix-II: 
 
REAGENTS  REQUIRED FOR SDS PAGE 
ELECTROPHORESIS : 
 
Working solutions  
1.Acrylamide stock (30%)-100ml 
       a.Acrylamide – 29.2g 
       b.Bisacrylamide – 0.8g  
       c. Add distilled water to make 100ml and stir till completely  
          dissolved 
2.Seperating gel Buffer (4x)-100ml 
       a.75ml 2M Tris-Hcl(pH 8.8)  - 0.5M 
       b.4ml 10% SDS                      - 0.4% 
       c.21ml of distilled water 
3. Stacking gel buffer (4x)          -  100ml 
        a. 50l 1M Tris-Hcl (pH 6.8)    -  0.5M 

        b. 4ml  10% SDS                     -   0.4% 
        c. 46ml of distilled water 
4. 10% Ammonium per sulphate (APS) -5ml 
         a. 0.5g APS dissolved in 5ml of distilled water 
5.Electrophoresis / Running Buffer (1x) – 1000ml 
          a. 3g Tris                               -           25mM 
          b.18.8g Glycine                     -           250mM 
          c.1g SDS                                -           0.1% 
          d. Distilled water to make it 1000ml 
6. Sample buffer -10ml 
          a.0.6ml 1M Tris – Hcl (pH6.8)   -    60mM 
          b. 5ml of 50% glycerol               -     25%    
          c. 2ml of 10% SDS                     -       2% 
          d. 0.5ml 2-mercaptoethanol        -       14.4mM 
           e.1ml 1% Bromophenol blue     -       0.1% 
           f. 0.9ml of distilled water 
7. Staining solution – 1000ml 

           a. 1.0g Coomassie Blue R-250 
           b. 450ml of methanol 
           c.  450ml Distilled water 
           d.  100ml of Glacial acetic acid 
8. Destaining solution  - 1000ml 
            a. 100ml Methanol 
            b. 100ml of Glacial acetic acid 
            c.  800ml of distilled water 
PREPARATION OF 10% SEPERATING AND 5% STACKING 
GEL : 
  FOR 10% SEPERATING GEL    FOR 5% STACKING GEL 
   Acrylamide stack        3.3ml    Acrylamide stack 1.6ml 
 Separating gel 
buffer 
       2.5ml Stacking  gel buffer 2.5ml 
     Distilled water        4.2ml      Distilled water 5.9ml 
          10%APS 50µl           10%APS 50 µl 

          TEMED 20 µl           TEMED 20 µl 
     Total volume  10ml     Total volume  10ml 
 
 
 
 
APPENDIX III  
REAGENTS FOR WESTERN BLOT : 
i) Transfer buffer                  
Tris                              3.0g 
Glycine                         4.5g 
Methanol                       200ml 
Distilled water make upto 1000ml 
(pH between 8.1-8.4 without adjustment) 
ii)     Phosphate buffered saline (pH 7.2) 
Na2HPO4                            5.76 gm 
Na2H2PO4 1.5gn 
NaCl                                     9.0gm 
Make the volume to 1000ml 
iii) Blocking solution  
3% BSA in PBS(7.2) 
iv) Substrate buffer (PBS-T) 

PBS (7.2) containing 0.1% Tween -20 
v)  Substrate solution for Horse Radish peroxidise 
20%  H2O2                            10 µl           
Substrate buffer                     10ml 
                Diaminobenzidine (DAB)       6mg 
vi)   Antibody / Conjugate dilution buffer 
0.55 BSA in PBS-T 
     vii)      Washing buffer (PBS-T) 
               PBS (7.2) containing 0.1% Tween – 20 (1ml of tween -20 in 
1litre of        PBS) 
    
 
DESTAINING SOLUTION : 
        1.25% Isopropyl alcohol 
        2. 10% Glacial acetic acid 
        3. Distilled water 
Ponceau’s stain : 
1. 2% ponceau stain powder 
2. 30% Trichloro acetic acid 
3. 30% Sulfosalicilic acid 
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                                                   PROFORMA 
A. PATIENT DETAILS 
1.Name   : 
2. Patient ID  no : 
3. Neurology no :  
4. Age  
5. Sex  
6. Residence  
7. Contact no  
8. Religion  
9. Occupation  
10. Socio-economic status 
 
B. HISTORY   
1.Presenting Illness  
1. Seizure : 
- Age of onset of seizures 
- New onset / chronic epileptic 
- Type of seizure – generalised / partial 
- Frequency of seizure 
2Associated symptoms – headache , vomiting 
3. Known case of tuberculosis 
2..Past History : 
- h/o contact with case of TB 
- h/o trauma 
3.Personal History : 
- h/o consumption of pork 
- toilet facilities  
- h/o passing worms in the stool 

- pig rearing 
- any pet dogs   
4. Family history : 
- Family h/o seizures 
- Known case of NCC among the family members 
5. Treatment History : 
- Anti epileptic treatment 
- Anti helminthic drugs 
6. Travel History : 
           h/o travel  to endemic countries 
 
C. CLINICAL EXAMINATION : 
1.General examination 
     Presence of subcutaneous nodules 
 
2. Systemic examination 
 Central nervous system  
 
 Cardiovascular system  
 
 Respiratory system 
 
D. CLINICAL DIAGNOSIS 
 
E. INVESTIGATIONS  
a. CT findings 
b. MRI findings 
    Normal study  
    Lesions suggestive of NCC  
- Granuloma / calcification/ ring enhancing lesion with 
central scolex 
F. Stool Microscopy: 
G. Serology  
1. ELISA  : positive / negative 
2. EITB : reactive / non reactive 
S.No H.No Name N.no Age Sex Residence new onsetchronic duration seizure type headache pork eating toilet facities AEDs stool miccroscopyMRI ELISA EITB del brutto 
1 78233 selvam 3452/12 27 M red hills       +         - 10d CPS no no yes no       -  normal study negative non reactive
2 8134 rajakumari 7345/12 40 F royapuram        -        + 30 yrs GTCS no no yes irregular      - normal negative non reactive
3 78809 ambika 6961/12 15 F pudhukuppam        +        - 4 months GTCS no no no no NA normal negative non reactive
4 78229 Geetha 1178/12 25 F vILLUPURAM        -        + 3 mons GTCS no yes no yes NA normal negative non reactive
5 8625 kauveri 6840/200 30 F Royapuram      -        + 12 yrs CPS no no yes yes       - normal negative non reactive
6 8592 Dillibabu 1602/12 15 M korukkupet       -        + 15 yrs GTCS yes no no yes NA Ring enhancing lesion negative non reactive
7 76630 nandha kumar 9007/12 42 M Muthiramerrur       +         - 5 mon GTCS no yes no no       - granuloma negative reactive* definitive
8 9639 devinandhini 7823/12 24 F red hills      +         - 4mon gtcs yes no yes no       - old granulomatous lesion in R parietal regionnegative non reactive
9 78681 Sivakumar 1184/12 17 M vILLUPURAM       +        - 2 mon CPS no no yes no NA granuloma brain ?NCC positive non reactive
10 79654 jayakumar 3456/10 45 m minjur       -       + 5mon GTCS no no yes no NA normal negative non reactive
11 9647 Ganesan 2523/4 14 m koodyanur        -        + 13 yrs GTCS no no yes yes NA normal negative non reactive
12 72343 vidhya 5645/12 27 F tondiarpet       -       + 6y GTCS no no yes yes       - normal negative non reactive
13 77689 rahman 5344/12 35 m washerman pet      -       + 2 yrs GTCS no no no yes NA normal negative non reactive
14 78559 selvi 6734/12 28 F thiruvallur       +       - 12 mon CPS no no no yes       - normal positive reactive
15 78504 eswari 8963/09 21 F korukkupet       +       + 16 y CPS yes no yes no       - acute granuloma L frontal gyrus ?ncc positive reactive probable
16 78553 selvi 7823/12 39 F parrys       -      + 20 y CPS no no yes yes NA normal negative non reactive
17 78567 vijay 8123/12 28 M washerman pet    +     - 20 days GTCS no no no no       - normal positive reactive
18 78738 marudhamalai 1194/02 20 m thiruvallur        -      + 13 yrs focal seizureno no yes no NA L frontal granuloma negative non reactive
19 78934 thairu nisha 2312/08 37 M washerman pet         -       + 6 yrs GTCS no no yes yes NA normal negative non reactive
20 78128 ramamoorthy 8233/12 48 M nettum      -       + 20y GTCS no no yes yes       - normal positive reactive
21 11589 santhosh kumar 7523/12 22 M red hills       +       - 20d GTCS yes no yes no NA normal negative non reactive
22 12675 kannagi 8723/12 38 F red hills      +        - 2 d GTCS  yes no yes no       - normal negative non reactive
23 12124 ravi 8905/12 25 F p.kottai       +       - 3mon GTCS yes yes yes no       - normal negative reactive
24 12658 Dilshan 4567/10 26 F vyasarpadi       -     + 5 y GTCS yes yes yes yes       - ring enhancing lesion positive reactive definite
25 14675 daksan 7623/12 43 m korukkupet     +       - 2months GTCS yes yes yes yes NA normal negative non reactive
26 14672 udayabharathi 5635/2 15 F P.nagar    +        - 4d CPS yes no yes no NA normal negative non reactive
27 14570 murugapandy 8742/12 22 M washerman pet      -         + 7y CPS  no no yas no NA normal negative non reactive
28 19648 ramkumar 1284/12 13 M royapuram         +      - 2weeks CPS yes no yes no       - normal positive non rective
29 11408 soundarapandiyan 5462/12 53 m thiruvottiyur     +            - 10d gtcs no no yes no NA multiple Ring Enhancing Lesions negative non reactive
30 79806 muthu 3042/12 68 m thiruvottiyur      -       + 1 y GTCS no yes no no NA normal positive reactive
31 79952 nalini 6152/12 42 f vyasarpadi        -         + 3 y GTCS no yes yes no       - normal negative non reactive
32 20694 nandhini 3120/12 20 f vyasarpadi      -    + 3 y GTCS no no no yes NA normal negative non reactive
33 21902 suriya 5609/10 14 m parrys     +        - 3mon GTCS yes no no no       - normal negative non reactive
34 79957 ajmer 6193/10 22 m manali          -         + 3 y GTCS yes no no no       - normal positive reactive
35 50162 rajavaran 5016/12 25 m tondiarpet       +       - 5 d CPS no yes yes no NA normal negative non reactive
36 79884 tmilselvi 8845/12 28 f thiruvottiyur      -      + 5y GTCS yes no no no NA normal negative non reactive
37 80290 divya 3402/12 17 f thiruvallur       -       + 15 yrs tcs no yes yes no       - normal negative non reactive
38 80296 lakshmi 2024/12 19 f korukkupet      -        + 2 yrs gtcs yes no no no NA normal negative non reactive
39 80298 krishnamoorthy 3012/12 39 m vyasarpadi        -        + 20y cps no no no yes NA normal positive reactive
40 80198 vani 1833/06 18 f thiruvottiyur         -        + 4y gtcs no no yes yes       - normal negative non reactive
41 80122 saral balmet 3492/12 54 f mambakkam        +         - 2 d gtcs no yes no no       - multiple Ring Enhancing Lesions positive non reactive
42 80345 arjunan 2077/`12 65 m minjur         +          - 6 mon cps no yes yes no NA normal negative non reactive
43 80580 gunasekaran 5673/12 20 m kalahasti        +       - 8mon gtcs yes no yes no NA granuloma negative non reactive
44 23046 pandiyan 3425/12 17 m aaradi          -      + 2 yrs gtcs no yes no no       - granuloma L parietal region ?NCC negative reactive probable
45 23021 suresh 8025/12 33 m pulianthope       -       + 33y gtcs no no no no NA normal negative non reactive
46 23546 patchiyappan 3962/6 23 m thiruvottiyur        _    + 18 y cps no no yes no NA REL negative reactive
47 24564 lakshmi 3927/12 26 f bharathi nagar      -           + 3y tcs yes no yes no       - normal positive reactive
48 24785 vadivel 5364/12 19 m vILLUPURAM      -       + 15y gtcs no no no yes       - normal negative non reactive
49 24165 ramesh 2453/2 24 m tondiarpet            +       - 4d CPS no no no no NA normal negative reactive
50 25122 khDER MOIDEN 5628/12 44 m washerman pet        -       + 15y GTCS no no yes yes NA calcification negative non reactive
51 81265 hemanth kumarr 8845/2 13 m washerman pet     -       + 1y cps no no no no NA normal negative non reactive
52 25456 nagaraj 7834/11 13 m tondiarpet      -        + 6y GTCS no no yes yes       - normal negative reactive
53 26346 priyadharshini 5432/12 13 f tondiarpet     +        - 10 d GTCS no yes yes no       - REL negative non reactive
54 26430 vanitha begum 5645/11 17 f washerman pet      -          + 12 yrs GTCS no no no yes NA normal positive non reactive
55 26897 suresh kumar 7865/6 24 f velllore      -        + 14y GTCS no no yes yes NA normal negative non reactive
56 27675 saravanan 3435/12 15 m kaasimedu        -           + 10y GTCS no no no yes       - normal negative non reactive
57 27756 devi 5546/2 27 f vyasarpadi  +     - 7 d GTCS no no yes no NA normal negative non reactive
58 27933 baby shalini 5673/12 13 f red hills       +             - 3 mons GTCS no no yes no NA normal negative non reactive
59 81234 koomathi 6342/12 25 f pulianthope      -     + 5 yrs GTCS yes no yes no       - normal positive mildly reactive
60 81212 kamesh 4599/12 32 m bharathi nagar      +      - 1week GTCS yes no yes no NA normal positive reactive
61 28190 praKASH 6123/2 30 M vyasarpadi       -          + 6MON GTCS yes yes yes no NA normal positive non reactive
62 28234 raziya sultan 6199/12 23 f koodyanur        -    + 1 year GTCS yes no yes yes       - normal negative non reactive
63 81267 devi 6178/2 17 f korukkupet       -           + 2y CPS no no yes yes NA normal negative non reactive
64 28111 mohan 5633/12 50 m royapuram      -    + 2y GTCS no yes yes yes NA granuloma positive reactive probable
65 28746 adiyamma 6477/3 35 f A.bakkam      -      + 10yrs GTCS yes no yes yes NA granuloma negative non reactive
66 81243 kanagaraj 4318/12 21 m washerman pet      +        - 2y CPS yes yes no no NA normal negative non reactive
67 81376 anandhi 6529/12 19 f tondiarpet          +   - 5 y GTCS yes no yes no NA normal positive reactive
68 29236 vedachalam 6734/12 32 m arani         -          + 3yrs GTCS yes no yes yes       - normal negative non reactive
69 29234 vankatesan 7623/12 34 m r.hills        +          - 2 weeks GTCS yes no yes no NA normal negative non reactive
70 29432 suriyan 6799/12 30 m Sharma nagar       +            - 7 d GTCS no no yes no NA normal negative non reactive
71 81379 Aruna 6783/12 48 m arani          -        + 1 yr GTCS no no yes yes NA R parietal speckle of calcification negative non reactive
72 81397 shekar 7012/12 14 m p.palayam       -         + 9yr GTCS no no yes yes       - normal negative non reactive
73 81423 padmavaty 7019/12 22 f korukkupet          +             - 4 d GTCS no no yes yes NA normal positive non reactive
74 20310 selvaraj 7123/12 55 m p.thope        +             - 3d GTCS no no yes no       - normal negative non reactive
75 81333 soundarya 7130/12 15 f ponneri           +             - 11mon CPS no no no no       - normal negative positive
76 29345 geetha 7590/12 24 f mayavaram        +       - 2months GTCS no yes yes no NA normal positive non reactive
77 29223 manjula 7623/12 35 f vilLUPURAM        -         + 4 y CPS no no yes yes NA normal negative non reactive
78 29241 gubendran 7699/12 15 m vILLUPURAM        +            - 3d CPS no no no yes       - ring enhancing lesion(acute granuloma in L occipital gyrus and old inactive granuoma in R superior frontal gyrus)positive positive pr bable
79 81629 udhayakumar 4146/12 48 m washerman pet          -            + 6 minths CPS yes no yes yes NA granuloma negative non reactive
80 29384 vasanti 3212/12 20 f washerman pet            + 1  1/2 y CPS yn yes yes yes       - normal negative non reactive
81 81656 geetha 2145/12 31 f minjur       -            + 4y GTCS no no yes yes NA normal positive reactive
82 81690 malliga 3490/12 45 f k.nagar         +             - 2d GTCS yes no yes yes       - normal negative reactive
83 81634 lokesh 6623/12 15 f ponneri        +              - 5d CPS yes no yes yes       - normal negative non reactive
84 81678 suresh 4329/12 25 f mandaveli          -             + 12 yrs GTCS no no yes yes       - granuloma positive reactive probable
85 81645 pavithran 4962/12 13 f r.hills         +              - 20 days CPS no no yes yes NA normal negative reactive
86 81578 raja 5432/10 17 m senji        -              + 2y GTCS no no yes yes NA normal negative non reactive
87 81690 thilakavathy 5674/12 17 f nettum        +               - 6mon GTCS yes no no no NA normal negative non reactive
88 81703 gopinath 7866/12 33 m koodyanur         -               + 13 yrs CPS no no no yes       - normal negative non reactive
89 81754 amudha 3487/12 22 f korukkupet         -               + 1 1/2 yrs GTCS no no yes yes       - normal negative non reactive
90 81796 abdul kathar 4577/12 25 m washerman pet         +         - 6mon GTCS yes no no no       - normal negative reaactive
91 81245 shankaran 6723/12 16 m red hills        +         - 3 wks GTCS yes no yes no NA normal negative non reactive
92 81823 divya 4783/12 26 f tondiarpet         +           - 3mon GTCS no no yes no       - normal negative non reactive
93 81817 mannar 4352/12 34 m royapuram          -         + 11 yrs GTCS no no yes yes       - normal negative non reactive
94 81745 devi 5634/12 45 f bharathi nagar           +          - 4mon GTCS no no yes no NA normal negative non reactive
95 81913 jenifer 7011/12 55 f royapuram          -         + 14 yrs CPS yes no yes yes       - normal negative non reactive
96 81934 jagan 5673/12 19 m parrys          +        - 1 d GTCS y no yes no NA normal negative non reactive
97 81967 eswari 4523/12 23 f tondiarpet          -        + 3 yrs GTCS no no no yes       - normal negative non reactive
98 81924 esther 7865/6 39 f minjur          -        + 5 yrs CPS yes yes yes no NA normal negative reactive 
99 81922 begum 4537/12 48 f korukkupet           -         + 10 yrs GTCS no no yes no       - normal negative non reactie
100 81945 muthu 5648/12 50 m korukkupet           -         + 8 yrs GTCS no no yes no       - normal negative non reactive
S.No H.No Age Sex pork consumption EITB S.No H.No Age Sex pork consumption EITB
1 324356 34 m no          - non reactive 26 49094 26 m no          - non reactive 
2 45231 28 m no          - non reactive 27 48887 27 f no          - non reactive 
3 23411 23 m no          - non reactive 28 47655 17 m no          - non reactive 
4 24673 15 m no          - non reactive 29 343678 53 f no          - non reactive 
5 23434 45 m no          - non reactive 30 34523 51 f no          - non reactive 
6 23455 19 m no          - non reactive 31 35784 34 m no          - non reactive 
7 32411 29 m yes          - non reactive 32 23563 29 m no          - non reactive 
8 32412 45 f no          - non reactive 33 45234 19 m no          - non reactive 
9 33210 27 m no          - reactive 34 46577 14 f no          - non reactive 
10 32567 25 f no          - non reactive 35 45323 23 f no          - non reactive 
11 32674 17 m yes          - non reactive 36 45673 16 m no          - non reactive 
12 32145 44 m no          - non reactive 37 45699 22 m no          - non reactive 
13 33782 40 m no          - non reactive 38 63424 54 m no          - non reactive 
14 33546 25 m no          - non reactive 39 45874 15 f no          - non reactive 
15 33780 29 f no          - non reactive 40 45346 32 m no          - non reactive 
16 34678 19 m no          - non reactive 41 56344 44 f no          - non reactive 
17 34526 18 m no          - reactive 42 26459 33 f no          - non reactive 
18 34522 32 f no          - non reactive 43 24354 38 f no          - non reactive 
19 34590 20 m no          - non reactive 44 45242 16 f no          - non reactive 
20 37689 32 m yes          - non reactive 45 56355 29 f no          - non reactive 
21 45232 30 f no          - non reactive 46 56332 33 m no          - non reactive 
22 34253 28 m no          - non reactive 47 56882 38 m no          - non reactive 
23 46523 46 m no          - non reactive 48 48265 15 f no          - reactive
24 44537 16 f no          - non reactive 49 58732 26 f no          - non reactive 
25 41786 40 f no          - non reactive 50 67454 60 m no          - non reactive 
NA - NOT AVAILABLE
REL - RING ENHANCING LESION
M-MALE
F- FEMALE
GTCS- GENERALISED TONIC CLONIC SEIZURE
CPS - COMPLEX PARTIAL SEIZURE

